Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MSITF - Medical Services Receives Registration in Russia
Tuesday August 22, 7:00 pm ET
EDMONTON, Alberta, Aug. 22 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF - News) is pleased to announce that it has received regulatory approval for its VScan HIV, Tuberculosis (TB) and Hepatitis C test kits in the Russian Federation. The Companies distributor in Russia "Intertest" A Pharmaceutical Company will immediately implement the marketing program for the approved VScan test kits. The Deputy of the General Director Ruzaev Evgeny Alexeevich who is responsible for the program feels that the demand for the VScan test kits will be substantial as a result of the independent testing completed and the regulatory approval. The VScan test kits continue to perform well wherever they are used. It is projected that sales will exceed 1,000,000 kits in the first year in Russia. The Company has obtained regulatory approval for the VScan HIV, TB and Hepatitis C test kits in both Russia and Ukraine. These two countries represent a large population that has a significant need for rapid test kits for HIV, TB and Hepatitis C.
The key to containing HIV and TB is early, fast, accurate testing. The VScan HIV test detects the IgM antigen that shows up in the blood within 2 to 11 days of HIV infection. The VScan TB test kit is the only test kit that measures only active TB and therefore does not give false positives. It is a fraction of the current cost of TB testing. TB is the number one killer of people with HIV/AIDS. It is projected by WHO that TB will kill over 8.0 million people this year. TB will kill more people this year than all other infectious diseases combined. Most TB is treatable with early detection.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Malaria, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or at http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies.
--------------------------------------------------------------------------------
Source: Medical Services International Inc.
BOCX - BioCurex Returns to the OTCBB
Tuesday August 22, 9:06 pm ET
RICHMOND, British Columbia, Aug. 22, 2006 (PRIMEZONE) -- BioCurex Inc. (OTC BB:BOCX.OB - News) announced today that following the filing of a Form 2C11, the National Association of Securities Dealers (NASD) has authorized the brokerage firm Lampost Capital L.C. (Boca Raton, FL) to quote BOCX shares on the OTC:BB (Over the Counter Bulletin Board) effective immediately.
Dr. Moro stated: ``We are thrilled by this achievement. It is the result of a very lengthy due diligence process that included direct conversations between the NASD and current and prospective future licensees. In a previous update we stated, 'We shall continue this process as many times as it takes, as there is more involved here than just a ''better exchange`` for trading our shares. There is the vindication aspect that we feel our company, our management team and our shareholders justly deserve.' We have achieved our goal in this arena, as we have done and continue to do in the technical, licensing and finance areas. All this has been accomplished while keeping costs and share dilution at a minimum. We feel vindicated and we thank Lampost for their trust, their efforts and their belief in our potential as a company throughout the time it took to get this listing approved.''
Dr. Moro stated, ``This is not the last step in our interest to maximize our exposure to the advanced markets. We will continue to seek global coverage of the company since our technology is applicable to all world markets.''
BioCurex Management wishes to congratulate and thank the company's shareholders for their support throughout this process
The company also wishes to advise its shareholders of information regarding its approach to the establishment of its patents. To date, the Company has received patents in the U.S.A., Russia, China and Australia. The company submitted a single patent application to the European Patent Office with over 40 claims rather than separate its diagnostic, imaging and therapeutic claims. Recently, the approach has not succeeded with the European Patent Office wherein approval for the single patent application has been denied, although we have not yet received an official response with the details from the EPO. It is the opinion of the attorneys in Europe that gaining approval in a subsequent action is probable once we separate the original claims under different applications in a process called ``separation in part.''
In addition, the Company is preparing and will file one or more new patents covering inventions developed in the past few moths. These inventions mainly relate to the RECAF blood tests and could extend our patent protection for another 17-20 years. These patents will not only be filed in Europe but also in the U.S.A. and other countries.
Finally, it is important to realize that the RECAF technology is very complex. Development of the technology is very tricky such that the proprietary ``know how'' in working with the RECAF family of molecules is critical and beyond the basic patent information. The company always includes this ``know-how'' in its licensing packages, and therefore can obtain significant royalties even in countries where there is no patent protection.
About BioCurex:
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(tm), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed a licensing agreement with Abbott Laboratories for BioCurex's RECAF(tm) Cancer technology as outlined in a joint press release dated March 29, 2005. The release noted that the cancer marker RECAF(tm) has emerged as a potential biomarker that may be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the most common cancers, including prostate, breast, colorectal, lung and others.
To read more about the Company, please visit the News section in our web site (http://www.biocurex.com).
Note:
The Company has not authorized the release of this information in any form that contravenes the Communication Act and will not be responsible for unsolicited massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this press release, which are not historical facts, are ``forward-looking statements'' within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
Contact:
BioCurex, Inc.
Ricardo Moro
(604) 207 9150
--------------------------------------------------------------------------------
Source: BioCurex, Inc.
BioCurex Returns to the OTCBB
Tuesday August 22, 9:06 pm ET
RICHMOND, British Columbia, Aug. 22, 2006 (PRIMEZONE) -- BioCurex Inc. (OTC BB:BOCX.OB - News) announced today that following the filing of a Form 2C11, the National Association of Securities Dealers (NASD) has authorized the brokerage firm Lampost Capital L.C. (Boca Raton, FL) to quote BOCX shares on the OTC:BB (Over the Counter Bulletin Board) effective immediately.
Dr. Moro stated: ``We are thrilled by this achievement. It is the result of a very lengthy due diligence process that included direct conversations between the NASD and current and prospective future licensees. In a previous update we stated, 'We shall continue this process as many times as it takes, as there is more involved here than just a ''better exchange`` for trading our shares. There is the vindication aspect that we feel our company, our management team and our shareholders justly deserve.' We have achieved our goal in this arena, as we have done and continue to do in the technical, licensing and finance areas. All this has been accomplished while keeping costs and share dilution at a minimum. We feel vindicated and we thank Lampost for their trust, their efforts and their belief in our potential as a company throughout the time it took to get this listing approved.''
Dr. Moro stated, ``This is not the last step in our interest to maximize our exposure to the advanced markets. We will continue to seek global coverage of the company since our technology is applicable to all world markets.''
BioCurex Management wishes to congratulate and thank the company's shareholders for their support throughout this process
The company also wishes to advise its shareholders of information regarding its approach to the establishment of its patents. To date, the Company has received patents in the U.S.A., Russia, China and Australia. The company submitted a single patent application to the European Patent Office with over 40 claims rather than separate its diagnostic, imaging and therapeutic claims. Recently, the approach has not succeeded with the European Patent Office wherein approval for the single patent application has been denied, although we have not yet received an official response with the details from the EPO. It is the opinion of the attorneys in Europe that gaining approval in a subsequent action is probable once we separate the original claims under different applications in a process called ``separation in part.''
In addition, the Company is preparing and will file one or more new patents covering inventions developed in the past few moths. These inventions mainly relate to the RECAF blood tests and could extend our patent protection for another 17-20 years. These patents will not only be filed in Europe but also in the U.S.A. and other countries.
Finally, it is important to realize that the RECAF technology is very complex. Development of the technology is very tricky such that the proprietary ``know how'' in working with the RECAF family of molecules is critical and beyond the basic patent information. The company always includes this ``know-how'' in its licensing packages, and therefore can obtain significant royalties even in countries where there is no patent protection.
About BioCurex:
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(tm), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed a licensing agreement with Abbott Laboratories for BioCurex's RECAF(tm) Cancer technology as outlined in a joint press release dated March 29, 2005. The release noted that the cancer marker RECAF(tm) has emerged as a potential biomarker that may be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the most common cancers, including prostate, breast, colorectal, lung and others.
To read more about the Company, please visit the News section in our web site (http://www.biocurex.com).
Note:
The Company has not authorized the release of this information in any form that contravenes the Communication Act and will not be responsible for unsolicited massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this press release, which are not historical facts, are ``forward-looking statements'' within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
Contact:
BioCurex, Inc.
Ricardo Moro
(604) 207 9150
--------------------------------------------------------------------------------
Source: BioCurex, Inc.
BOCX - BioCurex Returns to the OTCBB
Tuesday August 22, 9:06 pm ET
RICHMOND, British Columbia, Aug. 22, 2006 (PRIMEZONE) -- BioCurex Inc. (OTC BB:BOCX.OB - News) announced today that following the filing of a Form 2C11, the National Association of Securities Dealers (NASD) has authorized the brokerage firm Lampost Capital L.C. (Boca Raton, FL) to quote BOCX shares on the OTC:BB (Over the Counter Bulletin Board) effective immediately.
Dr. Moro stated: ``We are thrilled by this achievement. It is the result of a very lengthy due diligence process that included direct conversations between the NASD and current and prospective future licensees. In a previous update we stated, 'We shall continue this process as many times as it takes, as there is more involved here than just a ''better exchange`` for trading our shares. There is the vindication aspect that we feel our company, our management team and our shareholders justly deserve.' We have achieved our goal in this arena, as we have done and continue to do in the technical, licensing and finance areas. All this has been accomplished while keeping costs and share dilution at a minimum. We feel vindicated and we thank Lampost for their trust, their efforts and their belief in our potential as a company throughout the time it took to get this listing approved.''
Dr. Moro stated, ``This is not the last step in our interest to maximize our exposure to the advanced markets. We will continue to seek global coverage of the company since our technology is applicable to all world markets.''
BioCurex Management wishes to congratulate and thank the company's shareholders for their support throughout this process
The company also wishes to advise its shareholders of information regarding its approach to the establishment of its patents. To date, the Company has received patents in the U.S.A., Russia, China and Australia. The company submitted a single patent application to the European Patent Office with over 40 claims rather than separate its diagnostic, imaging and therapeutic claims. Recently, the approach has not succeeded with the European Patent Office wherein approval for the single patent application has been denied, although we have not yet received an official response with the details from the EPO. It is the opinion of the attorneys in Europe that gaining approval in a subsequent action is probable once we separate the original claims under different applications in a process called ``separation in part.''
In addition, the Company is preparing and will file one or more new patents covering inventions developed in the past few moths. These inventions mainly relate to the RECAF blood tests and could extend our patent protection for another 17-20 years. These patents will not only be filed in Europe but also in the U.S.A. and other countries.
Finally, it is important to realize that the RECAF technology is very complex. Development of the technology is very tricky such that the proprietary ``know how'' in working with the RECAF family of molecules is critical and beyond the basic patent information. The company always includes this ``know-how'' in its licensing packages, and therefore can obtain significant royalties even in countries where there is no patent protection.
About BioCurex:
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(tm), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed a licensing agreement with Abbott Laboratories for BioCurex's RECAF(tm) Cancer technology as outlined in a joint press release dated March 29, 2005. The release noted that the cancer marker RECAF(tm) has emerged as a potential biomarker that may be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the most common cancers, including prostate, breast, colorectal, lung and others.
To read more about the Company, please visit the News section in our web site (http://www.biocurex.com).
Note:
The Company has not authorized the release of this information in any form that contravenes the Communication Act and will not be responsible for unsolicited massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this press release, which are not historical facts, are ``forward-looking statements'' within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
Contact:
BioCurex, Inc.
Ricardo Moro
(604) 207 9150
--------------------------------------------------------------------------------
Source: BioCurex, Inc.
Oil Prices Slip on Iran's Offer
Wednesday August 23, 4:14 am ET
Oil Prices Slip on Iran's Offer to Continue Negotiations on Atomic Program
SINGAPORE (AP) -- Oil prices dropped slightly Wednesday as traders locked in profits in response to Iran's offer to continue negotiations on its nuclear program.
Traders also awaited the weekly U.S. inventory report, which was expected to show relatively small gasoline stock draws for this time of year, the prime American driving season.
Light, sweet crude for October delivery was down 18 cents to $72.92 a barrel in Asian electronic trading on the New York Mercantile Exchange. The September contract, which closed Tuesday, settled at $72.63 a barrel, up 18 cents.
October Brent crude on London's ICE futures exchange dropped 17 cents to $73.07 a barrel.
In other Nymex trading, natural gas futures rose 2.2 cents to $7.030 per 1,000 cubic feet. Gasoline futures dropped 0.93 cent to US $1.9300 per gallon, while heating oil futures fell 0.21 cent to $ 2.0345 per gallon.
The face-off between Iran, OPEC's No. 2 oil producer, and the West has worried traders for months. The U.N. Security Council passed a resolution last month calling for Iran to suspend uranium enrichment -- which could be used to create nuclear weapons -- by Aug. 31 or face the threat of economic and diplomatic sanctions. That has clouded the outlook for Iran's oil supplies.
In its official response to a package of incentives aimed at persuading Iran to suspend uranium enrichment, Tehran said Tuesday it was ready for "serious negotiations" on its nuclear program.
But a semiofficial news agency said the government was unwilling to abandon uranium enrichment -- the key U.S. demand -- and Iran's Supreme Leader Ayatollah Ali Khamenei had said Monday that Tehran will pursue nuclear technology.
"It seems the country has rejected (the incentives package), and this is as expected," said Koichi Murakami, an analyst with brokerage Daiichi Shohin in Tokyo. "Given that, traders are locking in profits."
In the weekly oil data from the U.S. Department of Energy, due out later Wednesday, crude oil and gasoline stockpiles are both expected to fall, according to a Dow Jones Newswires survey of analysts. The average drop expected in crude oil inventories was 1.1 million barrels.
The market is also concerned that hurricanes could strike Gulf of Mexico production and refining facilities.
GTW - Gateway receives offer for retail unit
Wednesday August 23, 2:18 am ET
NEW YORK (Reuters) - Lap Shun Hui, owner of Joui International and the former owner of eMachines, said on Tuesday he has submitted a bid to buy the retail operations of computer maker Gateway Inc. (NYSE:GTW - News) for $450 million.
In a letter to Gateway's board, Hui also said he would be willing to explore buying all outstanding shares in the whole company.
The offer for the retail operations was first submitted on August 3, but Gateway did not "constructively engage in discussions" with Hui and his advisers, the letter said.
Hui said that to compete effectively, Gateway must separate its retail operations from its other businesses and make changes to improve its margins.
Gateway said in a statement early on Wednesday that its board of directors will review the offer from Hui.
Gateway shuttered its 188 retail stores and now sells inexpensive PCs under the eMachines brand, which it bought in 2004, through major electronics retailers.
Hui's cash-free, debt-free proposal to buy the Gateway retail operations represents the equivalent of $1.21 per share, based on 372.2 million shares outstanding, he said in the letter.
Shares of Gateway closed at $1.72 on Tuesday on the New York Stock Exchange, up 12.4 percent.
Earlier this month, Gateway, the third largest U.S. personal computer maker, reported a second-quarter net loss of $7.7 million or 2 cents a share. During that period, revenue at its retail unit rose 21 percent to $592 million as it gained market share in the United States.
Over the past several years, Gateway has lost market share to industry leaders Dell Inc. (NASDAQ:DELL - News) and Hewlett-Packard Co. (NYSE:HPQ - News).
DBGFE - De Beira Announces that it has Signed an Agreement over the Condoroma and Suyckutambo Project Areas in the Cuzco Region of South Peru
Wednesday August 23, 4:22 am ET
PERTH, WESTERN AUSTRALIA--(MARKET WIRE)--Aug 23, 2006 -- DE BEIRA GOLDFIELDS INC. ("DE BEIRA" or the "Company") (OTC BB:DBGFE.OB - News)(FWB: D1Q)(WKN: A0JDS0) is pleased to announce that it has signed an agreement with the privately owned, Goldplata Group of companies over the Condoroma and Suyckutambo project areas in the Cuzco region of South Peru. Recent sampling of the project areas by De Beira provided the following results.
Surface grab samples from the historical mine area at the Condoroma Project produced the following results:
CN1 - 1,476g/t Silver, 4.02% Lead and 1.34% Zinc
CN2 - 1,325g/t Silver, 5.48% Lead and 1.37% Zinc
CN3 - 1,325g/t Silver, 1.33% Lead and 1.14% Zinc
CN6 - 5.14g/t Gold, 146g/t Silver, 8.06% Lead and 3.48% Zinc
CN10 - 22.4g/t Silver, 5.82% Lead and 1.36% Zinc
Grab samples from the vein systems at the Suyckutambo Project produced
the following results:
ST1 - 1.25g/t Gold and 78.2g/t Silver
ST2 - 8.44g/t Gold and 366g/t Silver
ST3 - 0.98g/t Gold and 84.7g/t Silver
ST4 - 4.71g/t Gold and 225g/t Silver
ST6 - 9.78g/t Gold and 470g/t Silver
ST8 - 6.85g/t Gold and 312g/t Silver
ST9 - 3.11g/t gold and greater than 100g/t Silver
ADVERTISEMENT
The Condoroma silver district, containing the historical Condoroma mine and located in the general vicinity of Tintaya at an altitude of 4,600m has been mined for silver since the Spanish colonial days. Several veins are visible within the Condoroma property though the historical mining focus was on 3 main vein systems, the Bonanza Vein, Ramil Vein and Santa Rita-Mercedes. The principal elements are silver with associated minor gold, and lead and zinc. The veins strike approximately N35-45 degrees west with a 60 to 90 degree southerly dip. The NE striking Santa Rita Vein intersects the Mercedes vein in an area, which the Company believes has the potential to host significant mineralisation. The numerous stock work veinlets within the system were tested with limited sampling by previous workers and show the veinlets to also be mineralised.
The highly encouraging results from the grab samples suggest the system may be host to a polymetallic deposit.
Mineralisation is hosted in volcanic intrusives of the Tacaza Group. Mineralisation style is epithermal veins of quartz-calcite-siderite-rhodochrosite gangue and pyrite-galena-sphalerite sulphides with manganese oxides and minor gold and electrum.
De Beira believes that the Condoroma property has the potential to be a large tonnage polymetallic deposit.
The Suyckutambo deposit also has had a history of mining dating back to colonial times. Recent activity saw mining of the area by Cia De Minas del Peru (MHC) between 1945 and 1965 with a 150 Tpd plant through which 1M tonnes was treated for 9.03M ounces of silver and 125,400 ounces of gold. The grades vary during the mine life of this time and eventually water inflow stopped the mine. De Beira believes that significant ore remains below the level of previous workings.
The commercial arrangements for Condoroma and Suyckutambo project areas are identical. De Beira can earn a 65% interest in each project area by sole funding exploration expenditure of US$4 million over a three year period. $500,000 expenditure is required before De Beira can withdraw from the arrangement. After earning a 65% interest, De Beira can elect to increase its interest to 70% by funding expenditure to bankable feasibility study stage or a further US$6 million in expenditure, whichever occurs first over a three year period. De Beira would be required to pay a 2% NSR royalty on any production in the future.
DE BEIRA GOLDFIELDS INC
Reg Gillard, President
About DE BEIRA GOLDFIELDS INC.
DE BEIRA is a Nevada based mineral exploration company. The Company has recently initiated a new program to evaluate undervalued assets for potential addition to its mineral claim portfolio.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains statements that plan for or anticipate the future, called "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of those terms and other comparable terminology.
These forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements about: our market opportunity; revenue generation; our strategies; competition; expected activities and expenditures as we pursue our business plan; the adequacy of our available cash resources; our ability to acquire properties on commercially viable terms; challenges to our title to our properties; operating or technical difficulties in connection with our exploration and development activities; currency fluctuations; fluctuating market prices for precious and base medals; the speculative nature of precious and base medals exploration and development activities; environmental risks and hazards; governmental regulations; and conduct of operations in politically and economically less developed areas of the world.
Many of these contingencies and uncertainties can affect our actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, us. Forward-looking statements are not guarantees of future performance. All of the forward-looking statements made in this press release are qualified by these cautionary statements. Specific reference is made to our most recent annual report on Form 10KSB and other filings made by us with the United States Securities and Exchange Commission for more detailed discussions of the contingencies and uncertainties enumerated above and the factors underlying the forward-looking statements. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov.
We disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.
This press release is for informational purposes only and is not and should not be construed as an offer to solicit, buy, or sell any security.
Contact:
Contacts:
De Beira Goldfields Inc.
Reg Gillard
Director
+61 (08) 9240 6717 / 9240 2836
+61 (08) 9240 2406 (FAX)
http://www.debeira.com
--------------------------------------------------------------------------------
Source: De Beira Goldfields Inc.
EPG - Environmental Power Announces Commencement of Development of Latest Renewable Natural Gas Production Facility in Texas
Wednesday August 23, 5:00 am ET
Cnossen Project Will Be Microgy's Fourth Large-Scale Renewable Natural Gas Production Facility in Texas
PORTSMOUTH, N.H., Aug. 23 /PRNewswire-FirstCall/ -- Environmental Power Corporation (Amex: EPG - News), a leader in the renewable biofuels industry, today announced that its subsidiary, Microgy, Inc., is developing its fourth large-scale, pipeline-quality renewable natural gas ("RNG") production facility at the Cnossen Dairy in Hereford, Texas. Together with the Huckabay Ridge project currently in construction, and the Mission Dairy and Rio Leche projects currently in development, this project is expected to increase Microgy's estimated annual RNG production capacity to approximately 2.6 million MMBTU annually upon completion of these facilities.
The planned Cnossen facility would be Microgy's fourth installation implementing its standardized, large-scale, eight-digester design, and will mirror the company's Huckabay Ridge facility under construction in Stephenville, Texas. The Cnossen facility, now entering the permitting stage, will process the waste from approximately 10,000 cattle, as well as other food industry waste. Once completed, Microgy's Cnossen facility will generate an estimated 650,000 MMBTU of pipeline-grade RNG annually (enough to heat approximately 11,000 homes), which will be compressed and delivered directly to a natural gas pipeline.
An affiliate of Microgy has entered into agreements with Cnossen Dairy for the siting of the facility and the supply of manure for processing by the facility. Cnossen Dairy is a new, state of the art production dairy, permitted for up to 14,000 cows and employing the latest technologies to maximize efficiency and minimize environmental impact.
"The planned Cnossen facility demonstrates our commitment to a strategy of deploying our modular, multi-digester design in order to increase RNG production capacity under our control," said Richard Kessel, CEO of Environmental Power. "Texas and other regions with large populations of cattle or swine are important markets for us, representing significant opportunities for the creation of profitable, RNG production facilities that deliver a 'green' natural gas equivalent. Our strategy is to accumulate RNG production capacity and to work with gas marketers to develop the best strategy to market our RNG so as to maximize the value of this unique product."
ABOUT ENVIRONMENTAL POWER CORPORATION
Environmental Power Corporation is a developer, owner and operator of renewable energy production facilities. Its principal operating subsidiary, Microgy, Inc., holds an exclusive license in North America for the development and deployment of a proprietary anaerobic digestion technology. Microgy is a developer of renewable energy facilities for the production and commercial application of methane-rich biogas from agricultural and food industry wastes. The biogas can be used to produce pipeline-grade methane or marketable biogas, liquefied natural gas, or LNG, renewable electrical energy or thermal energy, as well as other useful by-products. Environmental Power's other principal subsidiary, Buzzard Power Corporation, holds a 22-year leasehold interest in the waste-coal fired Scrubgrass facility. Scrubgrass generates 83 MW of electricity by burning more than 600,000 tons of waste coal annually from active and abandoned area mine waste dumps. For more information visit the Company's web site at http://www.environmentalpower.com.
CAUTIONARY STATEMENT
The Private Securities Litigation Reform Act of 1995, referred to as the PSLRA, provides a "safe harbor" for forward-looking statements. Certain statements contained in this press release, such as statements concerning planned manure-to-energy systems, our sales pipeline, our backlog, our projected sales and financial performance, statements containing the words "may," "assumes," "forecasts," "positions," "predicts," "strategy," "will," "expects," "estimates," "anticipates," "believes," "projects," "intends," "plans," "budgets," "potential," "continue," "targets" "proposed," and variations thereof, and other statements contained in this press release regarding matters that are not historical facts are forward-looking statements as such term is defined in the PSLRA. Because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to: uncertainties involving development-stage companies; uncertainties regarding project and other financing, the lack of binding commitments and/or the need to negotiate and execute definitive agreements for the construction and financing of projects, the sale of project output, the supply of substrate and other requirements and for other matters; financing and cash flow requirements and uncertainties; inexperience with the development of multi-digester projects; risks relating to fluctuations in the price of commodity fuels like natural gas, and our inexperience with managing such risks; difficulties involved in developing and executing a business plan; difficulties and uncertainties regarding acquisitions; technological uncertainties; including those relating to competing products and technologies; risks relating to managing and integrating acquired businesses; unpredictable developments; including plant outages and repair requirements; the difficulty of estimating construction, development, repair and maintenance costs and timeframes; the uncertainties involved in estimating insurance and implied warranty recoveries, if any; the inability to predict the course or outcome of any negotiations with parties involved with our projects; uncertainties relating to general economic and industry conditions, and the amount and rate of growth in expenses; uncertainties relating to government and regulatory policies and the legal environment; uncertainties relating to the availability of tax credits, deductions, rebates and similar incentives; intellectual property issues; the competitive environment in which Environmental Power Corporation and its subsidiaries operate and other factors, including those described in our most recent Annual Report on Form 10-K, well as in other filings we make with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date that they are made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT
Kam Tejwani, Vice Chairman of Environmental Power Corporation
(603) 431-1780
ktejwani@environmentalpower.com
Public Relations Contact:
John Abrashkin, Ricochet Public Relations
(212) 679-3300 x121
jabrashkin@ricochetpr.com
Investor Relations Contact:
John Baldissera, BPC Financial Marketing
1-800-368-1217
--------------------------------------------------------------------------------
Source: Environmental Power Corporation
Will ask this again...
getting a lot of PMs complaining about why this or that was left on the board.
please feel free to "PM" one of the moderators since we can't possibly catch every post.
no politics, sports, attacking anyone, no other stocks, keep it on suject please and TIA
lol USC Cowboy, you don't see the crap that is deleted, everyone has opinions, some are obviously collected here in opposition to anyone with a negative thing to say. One person sold today, there were at least 18 responses (I lost track)
bashing it, all I am trying to say is I have not lost control of nothing, the board is better then last week. and I will continue doing my best to find a fair balance.
{ps: and the pay sux)
* Please keep in mind that this is a stock specific board and is limited to discussions relating to SLJB only.
Its called thread disruption, folks have a hard enough time not attacking each other.
was just a thorn telling half lies just to get a rise. jmo
Tuslog28, Thank you....!
rover, it will be even more fun tomorrow ->
added to Banned list
noossab2001 8/22/2006 3:43:03 PM 2744
I think IMO 15 replies to Rockies 1 opinion is enough can we get back to SLJB TIA.
SLJB - WINDSOR, ON, Aug 22 (MARKET WIRE) --
Sulja Brothers Building Supplies, Ltd. (PINKSHEETS: SLJB) announced today
that the company is releasing the current share structure to the investing
public. Sulja Bros. currently has 800 million shares authorized with 500
million shares outstanding. All share counts have been rounded to the
nearest million.
CEO Steve Sulja stated: "The current outstanding shares are 500 million.
There are
362 million shares held by insiders. Of the 362 million insider shares, 162
million are restricted. There are 138 million shares in the public float.
The number of inside owners, of 10% of common class shares, decreased after the
reverse merger. The increase of outstanding shares from 200 million to 500
million excluded holders of 20 to 50 million shares from insider status.
Basically, three insiders with 40 million shares from the open market did not
meet the 10% of class rule; therefore, they are no longer considered
insiders."
This contains forward-looking information within the meaning of The
PrivateSecurities Litigation Act of 1995. Forward-looking statements may be
identified through the use of words such as "expects," "will," "anticipates,"
"estimates," "believes," or statements indicating certain actions: "may,"
"could," "should" or "might occur." Such forward-looking statements involve
certain risks
and uncertainties. The actual result may differ materially from such
forward-looking statements. The company does not undertake to publicly update
or revise its forward-looking statements even if experience or future changes
make
it clear that any projected results (expressed or implied) will not be
realized.
RADI - Israel Ministry of Defense Contracts RADA $330,000 to Provide Advanced Head Up Display Camera to the Israeli Air Force F-15 Aircraft
Tuesday August 22, 10:00 am ET
NETANYA, Israel, August 23 /PRNewswire-FirstCall/ -- RADA Electronic Industries Ltd. (NASDAQ: RADI - News) announced today that it was selected by the Israeli Ministry Of Defense (IMOD) to replace the aging Israeli Air Force (IAF) F-15 Head Up Display Cameras with RADA's state of the art "Eye Witness" color video camera. Initial order value exceeds $330,000 with deliveries scheduled for the first half of 2007. Additional orders to complete the whole IAF F-15 fleet upgrade are expected during 2007.
Commenting on the contract, Major General (Res.) Herzle Bodinger, RADA President and CEO said "We are proud to be the provider of airborne cameras to the IAF front line fighters. This contract increases the install base of RADA products in the IAF to the F-15 as well.
About RADA
RADA Electronic Industries Ltd. is an Israel based company involved in the military and commercial aerospace industries, with 110 staff. The company specializes in Avionics, Ground Debriefing Stations (Video, ACMI and Maintenance) and Automatic Test Equipment.
Note: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such risk uncertainties and other factors include, but are not limited to, changes in general economic conditions, risks in product and technology developments, market acceptance of new products and continuing product demand, level of competition and other factors described in the Company's Annual Reports on Form 20-F and other filings with the Securities and Exchange Commission.
Contact:
Elan Sigal- C.F.O
RADA Electronic Industries Ltd.
Tel: +972-9-8921111
--------------------------------------------------------------------------------
Source: Rada Electronic Industries Ltd
BLYC - Bentley Commerce Corp. and Its Former CEO, Bruce Kamm, Settle Lawsuits
Tuesday August 22, 10:02 am ET
BEVERLY HILLS, CA--(MARKET WIRE)--Aug 22, 2006 -- Bentley Commerce Corporation (Other OTC:BLYC.PK - News) (www.bentleycommerce.com) and Bruce Kamm, its former CEO, announced today that they have settled the lawsuits against each other and will work together to build a strong and profitable business for Bentley Commerce and its shareholders.
"We are delighted to put this chapter in our company's history behind us and devote our skills and energy to propel Bentley Commerce forward," said its CEO, Robert Schumacher. "We genuinely welcome Mr. Kamm back and look forward to again having his expertise and business acumen serve the Company. As we move ahead, we recognize his prior contributions and acknowledge that too often disagreements result from miscommunication."
"In the near term, Bentley Commerce will focus its barter and trade business on Corporate trade, a $50 billion market sector typified by large media, commercial and industrial transactions, rather than providing services to small retail barter exchanges," continued Mr. Schumacher. "In addition, Bentley Commerce will now actively seek other compatible business opportunities."
About Bentley Commerce Corporation:
Bentley Commerce Corporation (Other OTC:BLYC.PK - News) (www.bentleycommerce.com) is an ecommerce business-to-business services provider that established a collaborative online barter marketplace. The Company offers alternative payment solutions including trade, as well as management services and systems to small, mid-size and global companies.
Forward-Looking Statements:
With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences, therefore such projected events and anticipated results are not warranties or guaranties that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the company's website(s), and/or documents filed with the SEC, which are easily accessible in the EDGAR database system.
Contact:
Contact:
Bentley Commerce Corporation
Bob Schumacher
Email Contact
310-201-0800
http://www.bentleycommerce.com
--------------------------------------------------------------------------------
Source: Bentley Commerce Corporation
MEDX - Medarex and GenPat77 Announce Therapeutic Antibody Co-Development Agreement
Tuesday August 22, 6:00 am ET
PRINCETON, N.J., and BERLIN, Aug. 22 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX - News) and GenPat77 Pharmacogenetics AG, a privately held biopharmaceutical company focused on the development of immune modulatory products, have entered into a collaborative agreement to develop fully human therapeutic antibody products. The companies plan to use Medarex's UltiMAb Human Antibody Development System® to generate antibodies to novel disease targets provided by GenPat77.
Under the terms of the agreement, Medarex and GenPat77 plan to share product development and commercialization responsibilities on any antibody products resulting from this collaboration. Other financial terms of the agreement were not disclosed.
"We are pleased to have the opportunity to combine our fully human antibody technology with GenPat77's novel targets and to work together toward the development of potential new therapeutics for autoimmune diseases," said Donald L. Drakeman, President and CEO of Medarex.
Nalan Utku, CEO and President of GenPat77, adds, "We believe that Medarex's UltiMAb Human Antibody Development technology is an excellent solution for the generation of fully human antibodies against our therapeutic targets. We believe that we will have a successful collaboration with the Medarex team."
About GenPat77
GenPat77 is focused on the development of innovative immune modulatory products for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, prevention of transplant rejection and cancer. Based on a fundamental understanding of the human immune system, GenPat77 endeavors to target key proteins in the immune cascade and appropriately modulate the immune response according to each specific indication. For more information about GenPat77, visit its website at www.genpat77.com.
About Medarex
Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. Thirty-three of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with five of the most advanced product candidates currently in Phase III clinical trials. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at www.medarex.com.
Medarex Statement on Cautionary Factors
Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of antibody products in patients, uncertainties related to product manufacturing as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2005 and subsequent Quarterly Reports on Form 10-Q. There can be no assurance that such development efforts will succeed or that other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.
Medarex®, the Medarex logo and UltiMAb® are registered trademarks of Medarex, Inc. All rights are reserved.
--------------------------------------------------------------------------------
Source: Medarex, Inc.
repost...Warren Buffett on pink sheet stocks,
Posted by: 'STRIPER'
Warren Buffett on pink sheet stocks. I wonder if he would be interested in SLJB ? Read the article or email him some DD, lol !!! just a thought, but the article is ligit.........
Finding Bargains in the Market's Dark Corners
There's more to the pink sheets than penny-stock scams.
by Toan Tran / 04-13-05 / 06:00 AM /
Of the countless things I've learned from Berkshire Hathaway BRK.A BRK.B chairman Warren Buffett, one of the most influential came from an interview he gave to BusinessWeek in 1999. In that interview, Buffett said, "If I was running $1 million today, or $10 million for that matter, I'd be fully invested. ... It's a huge structural advantage not to have a lot of money. I think I could make you 50% a year on $1 million. No, I know I could. I guarantee it.”
While having billions of dollars to invest is a rather wonderful problem, Buffett is clearly handicapped by Berkshire's colossal size. His message to smaller investors is direct: If you want to achieve truly market-crushing returns, concentrate your research on the universe of small-capitalization stocks. Furthermore, as my colleague Curt Morrison pointed out in a recent article, illiquid stocks have outperformed liquid stocks by 2.1% annually over the past 40 years. These results, of course, make perfect sense. For various reasons, large investors cannot invest in small, illiquid stocks, and with fewer smart people looking at a stock there's a greater chance for mispricings. In my experience, the smallest and most illiquid stocks tend to trade on the pink sheets.
The 101-year-old pink sheets market, so named for the pink newsprint on which quotations used to be published, typically deals in the over-the-counter stocks of very small companies, and is the back alley of the stock market. Because companies trading on pink sheets are not required to file financial statements with the SEC or meet other regulatory obligations, the market is littered with all sorts of debris, including penny-stock frauds and the empty shells of bankrupt companies. Any recommendation of a pink-sheets stock, like the ones that may clutter your e-mail inbox, should immediately raise a red flag.
It may surprise you, then, that Warren Buffett has been known to shop in the pink sheets. In fact, any investor willing to look hard enough will find many fine businesses among the weeds, and when small capitalizations, illiquidity, and the stigma associated with the pink sheets intersect, they form a trinity of market inefficiency. The resulting mispricings can sometimes be glorious. If you think Google GOOG has done well, I know of a sleepy 112-year-old California citrus grower whose shares closed on the pink sheets at $73.50 on the date of Google's IPO (Aug. 19, 2004). Most recently the shares changed hands at $217, or a 195% return versus Google's 128% gain since its IPO. If that return figure piques your interest, here are a few tips to find potential bargains in the overlooked corners of the market.
Starting Your Search
Although it may sound quaint, the best way I've found to screen for pink sheets stocks is by flipping through the pages of a stock manual. Published annually, Walker's Manual of Unlisted Stocks contains financial summaries on 500 of the leading pink sheets stocks. The manual is an excellent resource because it filters out the stock scams and other rubbish. In addition, because financial information for these stocks is scarce, having condensed financial statements in one location greatly speeds up the research process. After finding a stock worthy of further research, your next challenge is obtaining full and audited financial statements. Some companies will publicly release their financials, but many will only share results with shareholders. In the latter case, your only shot at getting a look at the books may be to purchase a nominal number of shares.
The Value of Scuttlebutt
"Scuttlebutt" is legendary investor Phil Fisher's term for the proprietary insights you can gain about a business by doing your research legwork. Obtaining scuttlebutt is much easier with small companies, and your insights will often be a great deal more valuable. For example, digging up useful scuttlebutt about General Electric GE is almost impossible. Unless you are a major investor, GE's management isn't likely to grant you access to the company. And if you do uncover something that thousands of other investors have strangely missed, it would have to be one amazing insight to move the needle at a company with $150 billion of sales and multiple unrelated business divisions. On the other hand, the heads of many small companies are happy to answer questions, even from small investors (you may be one of a handful of people to ever ask about their businesses). Moreover, your insights do not have to be particularly blinding to make you a lot of money. The stock of the California citrus grower I mentioned earlier likely did not rise because the economics of oranges have improved; it's probably because growing oranges is no longer the highest and best use of the company’s land. (Orange County, Calif.--home to some valuable real estate--is so named because it used to be covered with orange groves).
Purchasing Shares
When you're ready to make a purchase, it pays to be extremely patient. The bid/ask spreads on the pink sheets are often jaw-dropping, so a market order is almost always a mistake. Unless you believe time is of the essence, you will be better served by putting up a limit order at the bid price and waiting for willing sellers. It may take you many weeks or months to accumulate a position, but you'll avoid paying bid/ask spreads that can amount to a significant percentage of the stock’s price. As always, you should only make a purchase if prices offer a margin of safety to your intrinsic value estimate.
Have an Owner Mentality
Warren Buffett has often said that he would be happy to hold his stocks even if the market were to close for the next 10 years. You should adopt the same mentality not only because it makes sense, but also because with pink sheets stocks the market may actually close for the next 10 years. Many stocks on the pink sheets lack an active market, so trading in and out is not possible. I own a stock that has not traded in over a year, but that hardly concerns me. The company’s results show me that intrinsic value continues to grow at a steady clip and the dividends clear just fine. I don't have the excitement of a daily quote, but I do own a piece of a valuable business obtained at a bargain price. Although it may take a few years, the return on my investment will take care of itself.
Illiquid Stocks on Major Exchanges
Investing in the pink sheets is not for every investor. Unless you have the time and inclination to thoroughly research your investments, it's best to stick to companies trading on major exchanges with regulatory oversight. Fortunately, even stocks that trade on the NYSE or NASDAQ can suffer the same pricing inefficiency due to small size and illiquid shares. For example, the opening paragraph of our Analyst Report on Student Loan STU should be music to the ears of many investors: "Although it's lightly traded and lacks a Wall Street following, Student Loan is a great business and has strong prospects." It is not surprising, then, that shares of Student Loan have appreciated significantly since it had a 5-star Morningstar Rating last fall. If you'd like to find the next stock that's been overlooked by the market, Morningstar's list of 5-star stocks is a good place to start.
http://news.morningstar.com/doc/article/0,1,131390,00.html
SYVT - Sysview Technology, Inc. Reports 71% Increase in Revenues for the Second Quarter of 2006
Monday August 21, 4:39 pm ET
SAN JOSE, CA--(MARKET WIRE)--Aug 21, 2006 -- Sysview Technology, Inc. (OTC BB:SYVT.OB - News) the world leader in USB powered portable image scanners and developer of HDTV (High Definition TV) technology solutions announces a 71% increase in revenues for its second quarter ended June 30, 2006.
The Company's revenues currently derived solely from its world leading mobile imaging scanning devices increased 71% to $2,539,000 for the second quarter ended June 30, 2006 as compared to $1,487,000 for the comparable period in 2005. This represents the 6th consecutive quarterly revenue increase for the company which has delivered revenue growth on its core image scanning business in 16 of the past 18 quarters. Revenues for the six month period ending June 30, 2006 increased 56% over the same period in 2005. The Company recognized a 46% increase in gross profits for the quarter ended June 30, 2006 and a 41% increase for the six months ended June 30, 2006.
The net operating loss for the first quarter ended June 30, 2006 was $(569,000) as compared to a net operating loss of $(1,211,000) for the comparable period in 2005. After inclusion of certain stock and warrant issuance costs related to a financing and certain stock based compensation cost's and change in fair value of derivative instruments, the Company's net loss for the second quarter ended June 30, 2006 was $(1,259,000) as compared to a net loss of $(807,000) for the comparable period in 2005.
"The growth in our mobile image scanning business has once again surpassed our expectations! It is the consistent success in this business that feeds our potential for great success in the HDTV display industry," commented Darwin Hu, Chairman and CEO. Mr. Hu went on to say that, "We continue to expand our Liquid Crystal On Silicon (LCOS) initiative and are excited about both the potential of the LCOS business and our position in it. We believe that we will deliver our LCOS solution including both imager and optical engine at a substantially lower cost of manufacturing than our competitors."
About Sysview Technology, Inc.
Sysview Technology, Inc. designs and manufactures imaging technology solutions for a worldwide customer base. The company currently manufactures and delivers over 21, proprietary mobile image-scanning products, which has allowed it to become the largest OEM private label manufacturer of USB powered mobile scanning systems in the world. Sysview's intellectual property portfolio in the imaging area consists of 19 patents with an additional 5 patents pending.
Recognizing the potential to leverage its years of imaging technology experience and manufacturing efficiencies, Sysview began developing new technologies targeting the HDTV display market. Products including its proprietary Nano-LCOS Imager and Next Wave Optical Light Engine, in various stages of development, are expected to begin reaching the marketplace in Q-1 2007. Additionally the Company is advancing its Sequential RGB LED Backlighting technology for LCD panels. These products and technologies are designed to significantly enhance picture quality, decrease power consumption, and enhance the viewing experience, while reducing the manufacturing costs associated with large screen High Definition televisions.
All trademarks and copyrights contained herein are the property of their respective holders.
Note on Forward-Looking Statements:
Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on current expectations and are subject to a number of known and unknown risks, uncertainties and other factors beyond our control that could cause actual events and results to differ materially from these statements. These statements are not guarantees of future performance, and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Sysview undertakes no obligation to update publicly any forward-looking statements.
Contact:
Company Contact:
Sysview Technology, Inc.
David P. Clark
(408) 213-3701
--------------------------------------------------------------------------------
Source: Sysview Technology, Inc.
CCCFF - Chai-Na-Ta Receives Unsecured Term Loan Facility from Major Investor
Monday August 21, 8:00 pm ET
RICHMOND, BRITISH COLUMBIA--(MARKET WIRE)--Aug 21, 2006 -- All amounts in Canadian dollars unless specified.
Chai-Na-Ta Corp. (the "Company") (OTC BB:CCCFF.OB - News), announced that the Board of Directors of the Company has approved a non-revolving term loan facility ("Loan") of HK$ 54.7 million (approximately $8.0 million) offered by More Growth Finance Limited ("More Growth"), a subsidiary of the Company's major investor, Road King Infrastructure Limited.
The unsecured Loan bears interest at 1.7% per annum over the HIBOR (Hong Kong Interbank Offered Rate) and is provided to the Company for a term of 48 months. The Loan will be used to enhance the Company's ability to meet working capital requirements during the upcoming harvest and to repay the existing HK$23.2 million (approximately $3.5 million) loans to More Growth that are repayable within the next year.
On March 29, 2006, the Company proposed to cancel the existing HK$23.2 million loans owed to More Growth in exchange for preferred shares. This proposal was approved by disinterested shareholders at the Company's Annual General Meeting on May 5, 2006. The Company will not be proceeding with this "shares for debt" transaction in view of the Loan and the alternative repayment arrangement it has made with More Growth.
Chai-Na-Ta Corp., based in Richmond, British Columbia, is the world's largest supplier of North American ginseng. The Company farms, processes and distributes North American ginseng as bulk root, and supplies processed material for the manufacturing of value-added ginseng-based products.
This news release contains forward-looking statements that reflect the Company's expectations regarding future events. These forward-looking statements involve risks and uncertainties, and actual events could differ materially from those projected. Such risks and uncertainties include, but are not limited to, the success of the Company's ongoing research programs, general business conditions, and other risks as outlined in the Company's periodic filings, Annual Report, and Form 20-F.
Contact:
Contacts:
Chai-Na-Ta Corp.
Wilman Wong
Chief Financial Officer/Corporate Secretary
(604) 272-4118 or Toll Free: 1-800-406-7668
(604) 272-4113 (FAX)
info@chainata.com
http://www.chainata.com
--------------------------------------------------------------------------------
Source: Chai-Na-Ta Corp.
Oil holds ground as Iran nuclear deadline nears
Tuesday August 22, 3:15 am ET
By Neil Chatterjee
SINGAPORE (Reuters) - Oil prices steadied on Tuesday at over $72 after a two-day rally, as Iran vowed to press ahead with its nuclear program, raising the prospect of sanctions against the world's fourth-largest oil exporter.
U.S. crude (CLc1) edged 2 cents down at $72.43 a barrel by 0700 GMT, after surging $2.39 in the past two trading days. London Brent crude (LCOc1) slipped 8 cents to $73.30 a barrel.
Iran is due to give its reply on Tuesday to a package on incentives by world powers that aims to end a nuclear stand-off with the West, but Supreme Leader Ayatollah Ali Khamenei vowed on Monday that Iran would continue its path on nuclear energy.
The United Nations Security Council has demanded that Iran halt its nuclear work by a deadline of August 31, raising the prospect of punitive action by the U.N.
"The main risk for the oil market is that we're closer to a time when Iran's oil -- the fourth-largest chunk of global production -- might not be on the market," said Tobin Gorey of the Commonwealth Bank of Australia.
Traders fear that Tehran may use its oil exports of more than 2 million barrels per day as a weapon to defend itself in the row. Officials have said sanctions will harm the West more than Iran by sending oil prices even higher.
President Bush on Monday urged the international community to act at the United Nations to curb Iran's nuclear ambitions and said there has to be a "consequence" for Tehran's actions.
Analysts say Iran is calculating any sanctions would start with modest steps, such as travel bans or asset freezes, while Moscow, Beijing and many European Union states may be unwilling to join sanctions that would jeopardize export contracts.
"The (oil) industry is desperately short of foreign exchange for investments -- money which can no longer be borrowed," said Fereidun Fesharaki of consultancy FACTS Inc. in an Iran report.
The Iranian concern has driven U.S. crude back up from a dip below $70 on Monday, which came after a ceasefire between Israel and Lebanon helped push prices down from a record $78.40 in July.
Israel gave U.N. environmental experts permission on Monday for an aerial survey of an oil slick that has spread along Lebanon's coast since Israel bombed a power station there five weeks ago.
Oil prices remain 19 percent up this year on the fear of disruption to Iran's exports and reduced Nigerian supplies.
Royal Dutch Shell (London:RDSA.L - News), Nigeria's largest foreign oil producer, is losing 495,000 barrels of oil equivalent per day of output it operates in Nigeria, mostly due to militant attacks on installations.
A partial outage in BP's (London:BP.L - News) Prudhoe Bay oilfield, the largest in the United States, was also expected to lead to a drop in U.S. crude inventories last week, industry analysts said in a Reuters survey (EIA/S).
Traders are keeping an eye on the fourth tropical depression of the 2006 Atlantic hurricane season, which formed on Monday in the far-eastern Atlantic and was expected to become Tropical Storm Debby, after hurricanes damaged U.S. production last year.
EXRCF - Exeter Resource Corporation: Cerro Puntudo Drilling Extends Gold and Silver Zones
Tuesday August 22, 4:00 am ET
VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 22, 2006 -- Exeter Resource Corporation (TSX VENTURE:XRC.V - News)(Other OTC:EXRCF.PK - News)(FWB: EXB) reports that drilling at its Cerro Puntudo Project in southern Argentina has encountered significant gold and silver mineralization, extending the depth of two known zones.
At the Rico Zone, reverse circulation hole CPRC-61 intersected 12 metres averaging 4.4 grams per tonne ("g/t") gold, including 1 metre grading 11.2 g/t gold, and 1 metre grading 34.1 g/t gold. Hole CPRC-62, located 40 metres to the north east, intersected 15 metres of 3.2 g/t gold and 13 g/t silver. Both holes were collared on the northern flank of Cerro Puntudo and intersected the mineralized zone 150 metres beneath the outcropping structure on the ridge.
At the Quebrada North Zone hole CPRC-64 intersected 9 metres grading 3.9 g/t gold and 8 g/t silver. The hole intersected the mineralized structure 120 metres down dip from the outcropping vein, 45 metres beneath previously-announced hole CPRC-50, which produced 9 metres grading 10.3 g/t gold and 39 g/t silver.
The drill program comprised 13 holes for a total of 1,699 meters and was designed to test the potential of three of five mineralized bodies discovered to date. Drill holes targeted mineralization at horizontal spacings of approximately 50 metres and 30 metres beneath previous intersections.
Significant Intersections for the recently-completed Puntudo drill
program are:
---------------------------------------------------------
RICO
---------------------------------------------------------
Hole No From To Interval Gold Silver
---------------------------------------------------------
(m) (m) (m) (g/t) (g/t)
---------------------------------------------------------
CPRC-60 91 100 9 1.0 30
---------------------------------------------
which includes
---------------------------------------------
96 97 1 4.9 124
---------------------------------------------------------
CPRC-61 115 119 4 1.7 4
---------------------------------------------
124 136 12 4.4 6
---------------------------------------------
which includes
---------------------------------------------
124 125 1 11.2 11
---------------------------------------------
and
---------------------------------------------
127 128 1 34.1 9
---------------------------------------------
139 140 1 0.8 19
---------------------------------------------------------
CPRC-62 128 143 15 3.2 13
---------------------------------------------
which includes
---------------------------------------------
130 131 1 7.0 21
---------------------------------------------
and
---------------------------------------------
138 139 1 8.3 21
---------------------------------------------
and
---------------------------------------------
142 143 1 7.7 7
---------------------------------------------------------
CPRC-63 118 126 8 0.9 16
---------------------------------------------------------
---------------------------------------------------------
QUEBRADA NORTH
---------------------------------------------------------
Hole No From To Interval Gold Silver
---------------------------------------------------------
(m) (m) (m) (g/t) (g/t)
---------------------------------------------------------
CPRC-64 99 108 9 3.9 8
---------------------------------------------
which includes
---------------------------------------------
106 107 1 6.9 32
---------------------------------------------
and
---------------------------------------------
107 108 1 13.4 27
---------------------------------------------------------
---------------------------------------------------------
QUEBRADA
---------------------------------------------------------
Hole No From To Interval Gold Silver
---------------------------------------------------------
(m) (m) (m) (g/t) (g/t)
---------------------------------------------------------
CPRC-70 106 116 10 0.3 34
---------------------------------------------------------
About Cerro Puntudo
Cerro Puntudo, like the Cerro Moro and Verde Silver projects, is one of a number of promising epithermal gold-silver properties held under Exeter's strategic agreement with Cerro Vanguardia S.A. (CVSA), an AngloGold Ashanti subsidiary.
At Puntudo, five zones of gold-silver mineralization hosted in veins and breccia bodies have been discovered to date. These bodies are aligned on a northwest-southeast striking fault that has been traced for over three kilometres. The new drilling has shown mineralization at both the Rico and Quebrada North zones to be open at depth.
Drill hole locations and geology, and a cross section through Rico can be viewed on the Exeter website at www.exeterresource.com, or by clicking on the following hyperlink: http://www.exeterresource.com/images/gallery/plans/plans16.pdf
Future Exploration at Cerro Moro, Verde Silver and Cerro Puntudo
Exeter has recently announced the discovery of bonanza grades (10 metres grading 15.4 g/t gold and 790 g/t silver) at the Cerro Moro Project (news release dated August 1, 2006) and the confirmation of multiple silver targets at the Verde Project (news release dated July 26, 2006). With the new results from Cerro Puntudo, Exeter has expedited ground exploration on these projects, in preparation for new drilling later this year.
Quality Control and Assurance
The gold and silver assay results presented above are preliminary and have been calculated using a 0.5 g/t gold equivalent cut-off grade, with no cutting of high grades. All reverse circulation drill samples were collected using a cyclone in one metre intervals. Samples were collected in accordance with industry standards. Samples were prepared at the ALS Chemex preparation facility in Mendoza, Argentina and assayed by fire assay (50 gram charge) at the ALS Chemex laboratory facility in La Serena, Chile, both ISO-9001:2000 certified laboratories.
Check assaying of all samples assaying greater than 1.0 g/t gold will be completed by ALS Chemex in Chile. The Company applies industry standard techniques for systematic inclusions of standard, blank and duplicate samples throughout the sample sequence as checks. Intersection widths presented above are drill core lengths and may not represent the true widths of mineralization.
Glen Van Kerkvoort, Exeter's Chief Geologist, a "qualified person" within the definition of that term in National Instrument 43-101, "Standards of Disclosure for Mineral Projects", has overall responsibility for Exeter's exploration programs in Patagonia and is responsible for the contents of this news release.
About Exeter
Exeter is a technically-advanced, Canadian gold exploration company, focused on the discovery and development of epithermal gold-silver properties in Argentina and Chile.
Currently, four drills are operating at its advanced La Cabeza gold project as a key component of project development activities that include engineering, metallurgical, hydrological, and environmental studies.
In the prospective, Patagonia region of Argentina, Exeter has a strategic agreement with Cerro Vanguardia S.A. over 12 epithermal gold-silver properties in Santa Cruz, Rio Negro and Chubut provinces.
In Chile, Exeter is prospecting some 48 gold-silver and copper targets under a strategic agreement with Rio Tinto Mining and Exploration Limited.
In the Maricunga district of Chile, Exeter has a strategic agreement with Minera Anglo American Chile Limitada and Empresa Minera Mantos Blancos S.A. on the Caspiche epithermal gold property.
You are invited to visit the Exeter web site at www.exeterresource.com.
To view the maps accompanying this press release, please click on the following link: http://www.ccnmatthews.com/docs/xrc0822.pdf
EXETER RESOURCE CORPORATION
Bryce Roxburgh, President and CEO
Safe Harbour Statement - This news release may contain certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 referring to Exeter's exploration plans and expectations for advancing its exploration properties. These statements reflect our current belief and are based upon currently available information. Actual results could differ materially from those described in this news release as a result of numerous factors, some of which are outside of the control of Exeter.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this news release.
Contact:
Contacts:
Exeter Resource Corporation
Bryce Roxburgh
President
(604) 688-9592 or Toll Free: 1-888-688-9592
Exeter Resource Corporation
Rob Grey
Investor Relations
(604) 688-9592 or Toll Free: 1-888-688-9592
(604) 688-9532 (FAX)
exeter@exeterresource.com
http://www.exeterresource.com
--------------------------------------------------------------------------------
Source: Exeter Resource Corporation
Out with the old...
In with the new...
According to name on jpeg from new IR site.
OK, FYI that was noossab's last post, can we get back to SLJB? TIA
Wall Street poised to fall on Iran fears
Monday August 21, 8:40 am ET
By John O'Doherty in New York
Wall Street was set to open lower on Monday, as oil prices moved higher following Iran's statement that it would continue its work on uranium enrichment. Ford Motor (NYSE:F) and Lowe's paced the fallers.
An hour before the opening bell, S&P 500 futures were 2.65 points below fair value, and Nasdaq Composite futures were 8.41 points below fair value.
Ford Motor lost 3.1 per cent to $7.75 after it announced production cutbacks, including the temporary closure of ten assembly plants, to reduce inventory and speed up its turnaround plan. Credit Suisse lowered its rating on the stock from "neutral" to "underperform".
Lowe's on Monday reported second quarter profits that fell short of analyst forecasts, and lowered its full year sales guidance. Its shares sank 3.5 per cent to $28.50 on the news.
Aetna (NYSE:AET) jumped 1.7 per cent to $37.21 in pre-market trading. Late on Friday, the company said it plans to reaffirm full-year earnings guidance later this month. The stock was further boosted by bullish comments in investor magazine Barron's.
Oil stocks were boosted by the higher crude prices. ConocoPhillips added 0.4 per cent to $66.65, and Occidental Petroleum (NYSE:OXY) rose 0.8 per cent to $52.85.
Sandisk fell 0.6 per cent to $50.88 on news reports that it was about to cut prices on its digital music players to compete with Apple Computer's iPod.
DGEO - Digital Ecosystems Changes Name to PetroHunter Energy -- Obtains New Trading Symbol: "PHUN"
Monday August 21, 9:00 am ET
DENVER, CO--(MARKET WIRE)--Aug 21, 2006 -- PetroHunter Energy Corporation (OTC BB:PHUN.OB - News) (formerly (OTC BB:DGEO.OB - News)), whose shares are traded on the Over-the-Counter Bulletin Board (OTC BB), will be trading under the symbol "PHUN" beginning on Monday, August 21, 2006.
In May 2006, PetroHunter Energy Corporation, formerly known as Digital Ecosystems Corp., acquired more than 85% of the stock of GSL Energy Corporation, and the business of GSL became the business of PetroHunter Energy Corporation. Subsequent to May 2006, PetroHunter Energy acquired all the remaining outstanding shares of GSL Energy.
About PetroHunter Energy Corporation
PetroHunter Energy Corporation, through the operations of its wholly owned subsidiary GSL Energy Corporation, is a global oil and gas exploration and production company with primary assets consisting of an undivided 50% working interest in oil and gas leases and related interests in various oil and natural gas prospects, including approximately 17,000 net mineral acres in the Piceance Basin of Colorado and seven million gross acres (3.5 million net acres) in the Northern Territory of Australia. In each of its principal areas of operation, the Company is obligated to pay the first $25 million of exploration and/or development costs incurred by its joint venture partner. GSL Energy Corporation was formed in June 2005 as a Maryland corporation and from May 12, 2006 completed a stock exchange by which its stockholders received more than 85% of the Company's outstanding stock and its business became the business of the Company. Subsequent to May 12, 2006, the Company acquired all the remaining outstanding shares of GSL Energy and, effective August 14, 2006, changed its name to PetroHunter Energy Corporation from Digital Ecosystems Corp. Its shares trade in the United States on the Over-the-Counter Bulletin Board (OTC BB).
Contacts:
PetroHunter Energy Corporation
Headquarters Office
1875 Lawrence Street
Suite 1400
Denver, Colorado 80202
Telephone: 303-572-8900
Facsimile: 303-572-8927
Kelly H. Nelson Chairman and CEO
(801) 363-8303
Garry Lavold President and COO
(303) 572-8900
Michael K. Lam Business Development
(416) 303-8810
Alexander Hubbard-Ford Business Development, Europe
44 79 8448 1541
Brad Long Investor Relations
(360) 322-4013
(866) 795-3436
Investor Relations Contacts
United States CTA Public Relations
Bevo Beaven Vice President/General Manager
(303) 665-4200
United Kingdom 4C Burvale
Carina Corbett, 44 (0) 20 7907 4760 / 4761
John Carrick Smith
Forward-Looking Statements
Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors over which PetroHunter Energy Corporation, or any of its divisions and subsidiaries, has little or no control.
Contact:
Contact:
Brad Long
Investor Relations
(360) 322-4013
(866) 795-3436
--------------------------------------------------------------------------------
Source: Digital Ecosystems Corp.
GEX - TelecityRedbus to Acquire Globix UK in $62 Million Deal
Monday August 21, 9:02 am ET
NEW YORK, Aug. 21, 2006 (PRIMEZONE) -- Globix Corporation, a leading provider of Internet infrastructure and managed services, today announced a definitive agreement to sell its wholly-owned subsidiary, Globix Holdings (UK) Limited (``Globix UK'') to TelecityRedbus, Europe's leading independent provider of colocation and data center services. The transaction is expected to close in three weeks and is subject to customary terms and closing conditions.
TelecityRedbus will pay US$62 million (approximately GBP33 million) for Globix UK and its associated pan-European network, which extends to the core business hubs of Paris, Amsterdam and Frankfurt. In addition, it will acquire two high-specification data centers, totalling 40,000 sft in central London, industry-leading Internet network infrastructure, a comprehensive portfolio of managed services and Globix' highly experienced team of technical and management specialists.
``The acquisition of Globix UK will enable new and existing customers to take advantage of one of Europe's most advanced data center networks. Few other players can claim such an advanced portfolio of high-tech data centers, Internet infrastructure and managed services, supported by such a well-respected team of technical consultants and account managers,'' said Mike Tobin, CEO of TelecityRedbus.
``It is this combination of assets that made Globix such an attractive acquisition target. It is no secret that we intend to grow our business through acquisitions, as well as organic growth, to further consolidate our position as one of Europe's most advanced hosting and managed data center service providers in Europe, and we believe the acquisition of Globix takes us a huge step closer towards this goal,'' concluded Mike.
Ted Lodge, Globix' Chairman of the Board of Directors and Executive Chairman, said: ``In late March of this year, Globix announced that it had hired the investment banking firm of The Bank Street Group LLC to assist it in reviewing strategic and financing alternatives for the company and its businesses. The sale of Globix UK is an outgrowth of that review, and we believe recognizes the value of Globix UK's strong position in the London data center market.''
``The acquisition brings great opportunities for Globix UK customers, staff and shareholders,'' said Philip Cheek, Managing Director of Globix UK. ``We're looking forward to working with the TelecityRedbus team to help customers to continue to take advantage of the Internet and the business opportunities it opens up for them.''
On completion of the acquisition, TelecityRedbus will have over 300 employees supporting 19 fully fitted data centers, totaling 550,000 sft, across seven European countries, making it one of Europe's largest and most advanced data center infrastructure and managed service providers.
TelecityRedbus projects a combined turnover of at least GBP76 million for 2006.
Forward-Looking and Cautionary Statements
Any statements contained in this press release that are not statements of historical fact, including statements about management's beliefs and expectations, are forward-looking statements and should be evaluated as such. The words ``anticipates,'' ``believes,'' ``expects,'' ``intends,'' ``plans,'' ``estimates,'' ``targets,'' ``projects,'' ``should,'' ``may,'' ``will'' and similar words and expressions are intended to identify forward-looking statements. Such forward-looking statements reflect, among other things, the Company's current expectations, plans, strategies and anticipated financial results and involve a number of known and unknown risks, uncertainties and factors that may cause the actual results to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to the following: our high degree of leverage and history of operating losses; our ability to retain existing customers and attract new customers; our ability to achieve cost-savings and generate positive cash flow; risks associated with potential acquisitions and divestitures, including the risk that such transactions may not close; and the other risks identified in the section entitled ``Risk Factors'' in the Company's Annual Report on Form 10-K for the year ended September 30, 2005, as well as in the other documents that we file from time to time with the Securities and Exchange Commission.
Many of these risks are beyond management's ability to control or predict. All forward-looking statements attributable to the or persons acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements and risk factors contained in this press release and the Company's filings with the Securities and Exchange Commission. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Except as required under the federal securities laws or the rules and regulations of the SEC, the Company does not undertake any obligation to update or review any forward- looking information, whether as a result of new information, future events or otherwise.
Notes to Editors
Combined customer list
TelecityRedbus will add Globix' 400 customers including Lloyds TSB, The Telegraph, Carphone Warehouse, 888.com and Ebookers, to its client base, which already includes major UK brands including the BBC, Guardian Unlimited, Sony Computer Entertainment and FriendsReunited, creating a combined UK customer base of over 2,000.
About TelecityRedbus
TelecityRedbus, Europe's foremost data centre services provider, is enabling businesses to meet the demands of today's 24x7 economy. Through its 17 carrier-diverse data centre facilities and round the clock engineering support across seven countries throughout Europe, TelecityRedbus offers content rich digital businesses, corporate enterprises, communications service providers and the public sector flexible and scalable data centre solutions. Over 1,600 organisations across Europe trust TelecityRedbus with their mission critical infrastructures. http://www.telecityredbus.com
About Globix Corporation
Globix Corporation (AMEX:GEX - News) is a leading provider of Internet infrastructure and network services. Globix offers a comprehensive suite of services from network bandwidth, to the management of Web applications, servers, and databases, to security, media streaming, and colocation. NEON, a wholly-owned subsidiary of Globix since March 2005, provides advanced optical networking to carriers and large enterprise customers in the Northeast and mid-Atlantic. Globix and its subsidiaries have operations in New York, NY, Westborough, MA, London, UK, Santa Clara, CA, and Fairfield, NJ. For more information, visit http://www.globix.com.
The Globix Corporation logo is available at http://media.primezone.com/prs/single/?pkgid=487
Contact:
TelecityRedbus:
James Tyler, Head of Communications
+ 44 (0) 20 7519 4858
james/tyler@telecityredbus.com
Helen Barnes, Marketing & Communications Manager (UK & Ireland)
+44 (0) 20 7001 0123
helen.barnes@telecityredbus.com
Hotwire Communications
Alex Maclaverty
+44 (0) 20 7608 4636
alex.maclaverty@hotwirepr.com
Rebecca Honeyman
+44 (0) 20 7608 4637
rebecca.honeyman@hotwirepr.com
Globix UK:
Christian Eckley, Sales & Marketing Director
+44 (0) 20 7611 3265
ceckley@globix.com
Nelson Bostock Communications
Caroline Howlett
caroline.howlett@nelsonbostock.com
Dan Warren
dan.warren@nelsonbostock.com
+44 (0)20 7229 4400
--------------------------------------------------------------------------------
Source: Globix Corporation
ECFL - Lists Over 100 Vehicles
Monday August 21, 9:05 am ET
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit
LAKE HARMONY, PA--(MARKET WIRE)--Aug 21, 2006 -- eCarfly, Inc. (Other OTC:ECFL.PK - News) announced the company has re-established on-line auctions with over 100 vehicles listed. eCarfly will continue with vehicle listings from all over the country due to the overwhelming response. In addition to the vehicle listings, eCarfly will begin listing industrial equipment, personal watercraft and ATVs.
About eCarfly, Inc.
eCarfly provides individuals and automotive dealers a hassle-free and cost-effective alternative to sell their vehicles while reducing traditional costs associated with the vehicle sales process to zero. With the knowledge, experience, and understanding of the automotive industry, eCarfly knows exactly what works and what doesn't. eCarfly is currently focusing on online vehicle sales and auctions, personal watercraft auctions, and partnerships with companies such as AutoNation and private individuals interested in selling their personal vehicles.
To read the complete release, go to http://biz.yahoo.com/bw/060818/20060818005223.html?.v=1
Other active stocks are XM Satellite Radio Holdings Inc. (NASDAQ:XMSR - News), Whole Foods Market, Inc. (NASDAQ:WFMI - News) and Integra Life Sciences Holdings Corporation (NASDAQ:IART - News).
ADVERTISEMENT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $500.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
Contact:
Contact:
C.P. Barry
Company: http://www.IOCircuit.com
Phone: 1.888.478.7669
--------------------------------------------------------------------------------
Source: IO Circuit
AMXG - AmMex Gold Mining Corp. Completes Corporate Restructuring with Cancellation of 57.6 Million Restricted Shares
Monday August 21, 9:10 am ET
OTTAWA, CANADA, August 21 /CNW/ - AmMex Gold Mining Corp. (OTCBB:AMXG - News; FWB:R5E) is pleased to announce the completion of the corporate restructuring from Reese Corp. to AmMex Gold Mining Corp. which includes the cancellation of 57.6 million restricted shares of the company's common stock. This restricted block of stock was held by Reese Corp.'s previous President, Boris Machula, and the cancellation was part of his agreement with the Company when he stepped down as both President and Director in early July 2006. AmMex Gold Mining Corp. now has approximately 40 million shares outstanding on a fully diluted basis.
AmMex Gold is now trading under the stock symbol AMXG on the OTC Bulletin Board, reflecting the recent name change from Reese Corp. to AmMex Gold Mining Corp. Reese Corp's common stock previously traded under the symbol "RESE".
Chris Crupi stated, "I am very pleased to complete this restructuring and will now focus on building AmMex Gold into a significant precious metals company. We have initiated this process with the acquisition of the Bailey Hills and Ox Creek projects in Nevada, along with the El Tiliche project in Mexico. We will continue to leverage our strong technical team to evaluate and acquire other advanced-stage projects."
About AmMex Gold
AmMex Gold Mining Corp. is a precious metals exploration and development company. It is management's objective for AmMex Gold to become a gold and precious metals producer by developing the El Tiliche project in Mexico, the Bailey Hills and Ox Creek properties in Nevada, and by acquiring other advanced-stage projects and/or producing mines in proven precious metal districts throughout the world. The Company trades on the OTC market under the symbol "AMXG" and on the Frankfurt Exchange under the symbol "R5E". For more information, please visit the Company's web site at: www.ammexgoldmining.com (now available in the following languages: English, German, Mandarin, Spanish and French).
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.
For further information
Investor Relations: Skyline Communications, 613-226-9881 Toll-free: 1-866-481-2233
--------------------------------------------------------------------------------
Source: AmMex Gold Mining Corp.
USXP - Business Surges for Universal Express' Luggage-Delivery Brands among Individual Air Travelers as Companies Rally to Form Marketing Partnerships with Logistics Pioneer
Monday August 21, 8:00 am ET
NEW YORK--(BUSINESS WIRE)--Aug. 21, 2006--Universal Express Inc. (OTCBB: USXP - News). "As a result of the terrorist events in the U.K., Universal Express, Inc., a pioneer in luggage-delivery services, is seeing a 19 percent surge in individual bookings for its Luggage Express and Virtual Bellhop brands within a week, domestically and in Europe, and the company is anticipating wider growth as a large number of global companies in the travel industry are eagerly turning to the diversified logistics company to forge marketing partnerships so they can offer consumers a secure, timesaving and stress-free convenience," announced Richard A. Altomare, CEO, Universal Express, Inc. (OTCBB:USXP - News) and Founder and Chairman of The Coalition for Luggage Security.
"With the airport terror plot, new regulations and the airlines' creaky baggage systems putting fliers in a tailspin, upscale companies in the travel industry that we've been courting for alignments are now calling us, eager to come to the table to forge innovative marketing partnerships with our brands as a way to provide a security service that is more than a luxury - it's a necessity," said Mr. Altomare. "Since the August 10 terror plot in London was foiled we've signed six partnership contracts with leading companies in the travel industry." Universal Express, based in Boca Raton, Fla. and New York, partners with more than 50 organizations including hotels, credit card companies, cruise lines, travel agencies, tour operators and other leaders in the travel industry.
Universal Express introduced its Virtual Bellhop (www.virtualbellhop.com) and Luggage Express (www.usxpluggageexpress.com) brands in 1997 and both services operate from the same facility in Boca Raton. Baggage travels through sophisticated baggage movement systems and software. The company carved out this specialty niche from its array of logistics and air courier services. Within two years competition started heating up and today there are about eight players in the market, some of which concentrate on niches like sports equipment.
"In this age of terrorism and the urgent need for security, Luggage Express, Virtual Bellhop and our competitors are experiencing brisk business because a consumer need is being met," said Mr. Altomare. "Increasingly, travelers are finding a new way to avoid getting frazzled by ever-changing restrictions, rules and long lines. Traveling without luggage takes experiential knowledge because it's a different way of acting or behaving."
The Luggage Express and Virtual Bellhop services started out domestically and have since expanded worldwide to most countries, except Cuba, delivering baggage from a home or business to its destination and then back again using air or ground transportation. Of Luggage Express, Mr. Altomare explained the brand is registered in 10 different languages, with more to come.
"Today we look at travelers in a general sense, not just as business travelers or vacationers," said Mr. Altomare. "People are merging their business with leisure activities. We've moved approximately five million cases over the past nine years with most of our customers renewing. Once people have luggage shipped ahead, they can't see how they ever lived without it especially in today's terror climate."
Mr. Altomare explained the biggest misunderstanding for most American travelers is assuming their luggage travels for free. "The airlines are losing $11 billion a year and their luggage costs total $9 billion of that figure," he said.
About Universal Express
Universal Express, Inc. is a 22 year old logistics and transportation conglomerate with multiple developing subsidiaries and services. For additional information please visit www.usxp.com
Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
For Investor Relations:
Universal Express, Inc.
Mark Falk, 631-588-1644
publicrelations@usxp.com
--------------------------------------------------------------------------------
Source: Universal Express Inc.
CHINA - CDC Games Acquires PRC License for the No. 1 Online Game in Korea's Internet Cafes
Monday August 21, 7:19 am ET
BEIJING, Aug. 21 /Xinhua-PRNewswire-FirstCall/ -- CDC Games, a wholly owned subsidiary of China.com Inc, a business unit of CDC Corporation (Nasdaq: CHINA), today announced that it has acquired the PRC license to the No. 1 online game in Korea's Internet cafes, Special Force, from its developer Dragonfly.
Special Force was launched in Korea in July 2004 and has been the top ranked online game in Korea's Internet cafes for the past year with close to 12% market share in a recent survey by a leading games research company. It has over 11 million registered users and a professional league with 36 teams and the richest prize money for online gaming in Korea. It is a military First Person Shooter online game where the players can create their own elite military units with customized weapons and equipment selected from those used by special forces from around the world such as the SAS and Delta Force.
Following in the pioneering footsteps of Yulgang, CDC's blockbuster online game in China, Special Force will be free to play with players paying for virtual merchandise. Special Force will leverage the nationwide server network developed by CDC Games to support Yulgang's operations. The new game is expected to launch in Q4, 2006.
"Dragonfly is excited to be partnering with CDC Games, one of the most successful online game companies in China. Based on their outstanding track record we have very high hopes for this new game in China. We look forward to a long and successful partnership with them," said Mr. C. W. Park, Chief Executive Officer of Dragonfly.
"We are proud to bring one of Korea's most popular games to our users in China," said Dr. Xiaowei Chen, Chief Financial Officer of China.com Inc. "With the continuing success of Yulgang and the enormous potential we see for Special Force, CDC Games is well positioned to continue to grow and maintain its position as a leader in online gaming in China."
About CDC Corporation
The CDC family of companies includes CDC Software focused on enterprise software applications and services, CDC Mobile focused on mobile applications, CDC Games focused on online games, and China.com focused on portals for the greater China markets. For more information about CDC Corporation (Nasdaq: CHINA), please visit www.cdccorporation.net .
About CDC Games
CDC Games Limited is focused on building a diversified mix of online game assets and strategic alliances and is a wholly owned subsidiary of China.com Inc. CDC Games is one of the market leaders of online and mobile games in China with over 30 million registered users.
About China.com Inc.
China.com Inc. (HK GEM Stock Code: 8006; website: www.inc.china.com ), a leading Online game, MVAS and Internet services company operating principally in China, and a 77%-owned subsidiary of CDC Corporation, was listed on the GEM of the Stock Exchange of Hong Kong Limited on March 9, 2000. In December 2000, China.com Inc. was admitted as a constituent stock of the Hang Seng IT and IT Portfolio Indices.
About CDC Mobile
CDC Mobile is the wholly owned subsidiary of China.com Inc. and is focused on providing MVAS products to subscribers in China.
About CDC Software
CDC Software, The Customer-Driven Company(TM), is a provider of comprehensive enterprise software applications and services designed to help businesses thrive and become customer-driven market leaders. The company's industry-specific solutions are used by more than 5,000 customers worldwide within the manufacturing, financial services, health care, home building, real estate, and wholesale and retail distribution industries. CDC Software's product suite includes Pivotal CRM (customer relationship management), c360 CRM add-on products, industry solutions and development tools for the Microsoft Dynamics CRM platform, Ross ERP (enterprise resource planning) and SCM (supply chain management), IMI warehouse management and order management, Platinum China HR (human resource) and business analytics solutions. CDC Software is ranked number 18 on the Manufacturing Business Technology 2006 Global 100 List of Enterprise and Supply Chain Management Application vendors. For more information, please visit www.cdcsoftware.com .
Cautionary Note Regarding Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to risks and uncertainties and changes in circumstances. There are important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, including the following: the ability of CDC Games to launch and operate Special Force, the popularity of Special Force in China, the ability of CDC Games to acquire additional online games, the ability of China.com Inc. to grow its online game business both organically and through targeted acquisitions; the ability to realize strategic objectives by taking advantage of market opportunities; the ability to make changes in business strategy, development plans and product offerings; and regulatory developments in China. Further information on risks or other factors that could cause results to differ is detailed in filings or submissions with the United States Securities and Exchange Commission made by CDC Corporation in its Annual Report for the year ended December 31, 2005 on Form 20-F filed on June 21, 2006. All forward-looking statements included in this press release are based upon information available to management as of the date of the press release, and you are cautioned not to place undue reliance on any forward looking statements which speak only as of the date of this press release. The company assumes no obligation to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
For More Information:
CDC Corporation
Investor Relations
Craig Celek
Tel: +1-212-661-2160
Email: craig.celek@cdccorporation.net
Media Relations
Ida Ho
Tel: +852-2237-7181
Email: ida.ho@hk.china.com
--------------------------------------------------------------------------------
Source: CDC Corporation
GERN - Geron Presents Data On HIV/AIDS Drug Candidate at the XVI International AIDS Conference
Monday August 21, 7:30 am ET
MENLO PARK, Calif.--(BUSINESS WIRE)--Aug. 21, 2006--Geron Corporation (Nasdaq:GERN - News) announced today the presentation of new data supporting the development of TAT0002, a small molecule telomerase activator for the treatment of HIV/AIDS, at the XVI International AIDS Conference in Toronto.
The data, which were presented by Calvin Harley, Ph.D., Geron's chief scientific officer, and co-authored by collaborating scientists at the Geffen School of Medicine at UCLA, confirm and extend earlier findings that TAT0002 enhances the function of key immune cells from HIV/AIDS donors. The results show that TAT0002 stimulates RANTES, MIP1-alpha and MIP1-beta, molecules that attract other immune cells to assist in the anti-viral response.
As in previous functional studies, the activity of TAT0002 was blocked by co-treatment with a potent and specific telomerase inhibitor, suggesting that TAT0002 works through telomerase activation. TAT0002 was previously shown to stimulate the production of IFN-gamma -- a molecule involved in the anti-viral response of cytotoxic CD8 T-cells specific for the HIV-1 AIDS virus -- and to enhance the ability of the CD8 cells to proliferate and kill HIV-1-infected CD4 cells.
Dr. Harley also presented data showing that TAT0002 is orally bioavailable in animals. These studies, in conjunction with pilot toxicology results, suggest that therapeutic blood levels of TAT0002 can be achieved with safe, oral doses of TAT0002.
"The new studies demonstrate that our orally available telomerase activator drug broadly reactivates anti-HIV immunity in AIDS patients' lymphocytes," said Thomas Okarma, Ph.D., M.D., Geron's president and chief executive officer. "The lymphocytes are the primary mechanism for containing HIV infection early in the course of the disease. Over time, telomere loss in these cells results in the gradual decline of their anti-HIV function, leading to clinical disease progression. Our hope is to use TAT0002 to prevent this immune decline and thereby prevent HIV progression."
TAT0002 is being developed at TA Therapeutics Ltd., a joint venture between Geron Corporation and the Biotechnology Research Corporation, a company established by the Hong Kong University of Science and Technology (HKUST). For more information on HKUST, visit www.ust.hk.
Geron is a Menlo Park, Calif.-based biopharmaceutical company that is developing and intends to commercialize first-in-class therapeutic products for the treatment of cancer and degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Geron's products are based on the company's core expertise in telomerase biology and human embryonic stem cells. For more information, visit www.geron.com.
This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding future applications of Geron Corporation's telomerase activator compound constitute forward-looking statements involving risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, need for additional capital, reliance on collaborators, need for regulatory approvals or clearances, and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Geron's periodic reports, including the quarterly report on Form 10-Q for the quarter ended June 30, 2006.
Contact:
Geron Corporation
David L. Greenwood, CFO, 650-473-7765
info@geron.com
or
Noonan Russo
David Schull, 858-546-4810 (Media)
david.schull@eurorscg.com
Sharon Weinstein, 212-845-4271 (Investors)
sharon.weinstein@eurorscg.com
--------------------------------------------------------------------------------
Source: Geron Corporation
GSEG - Sterling Planet Supplies 18 Million kWh of Wind Energy Credits to National Envelope
Monday August 21, 7:30 am ET
NEW YORK--(BUSINESS WIRE)--Aug. 21, 2006--National Envelope, the world's largest envelope manufacturer has signed a multi-year contract with Sterling Planet for the purchase of 18 million kilowatt hours of Renewable Energy Credits from wind energy projects located nationwide.
Wind energy is the fastest growing source of electricity in the USA. The National Envelope purchase serves to avoid the release from conventional electricity generation of approximately 25,056,000 pounds of carbon dioxide, the leading greenhouse gas. The environmental benefit compares to not taking nearly 10,000 drives between Los Angeles and New York City.
With this purchase, National Envelope gains entry into the Environmental Protection Agency's Green Power Partnership and its Green Power Leadership Club. To become a Partner, organizations replace a portion of their annual electricity consumption with green power. The Green Power Leadership Club further honors Green Power Partners that have made an exemplary green power purchase that significantly exceeds minimum Green Power Partnership purchase requirements.
National Envelope has a long-standing commitment to the environment, environmentally-sound products and eco-friendly business practices. For example, National Envelope is the first and only envelope converter in the United States to be certified to produce envelopes, announcements, and greeting cards that are accepted as meeting the standards of the Forest Stewardship Council and the Sustainable Forestry Initiative® program.
"This purchase of wind credits from Sterling Planet demonstrates our focus on being a good corporate citizen," says Nathan Moser, CEO. "We selected Sterling Planet as our provider because we were looking for the greatest value that would enable us to do our part for the environment while continuing to deliver the best quality envelopes at the lowest cost."
Renewable Energy Credits, also known as RECs, represent the environmental benefits of generating electricity by use of renewable energy sources such as the wind and sun. RECs are sold separately from the electrical output of renewable energy projects and are available to residential and non-residential customers nationwide through Sterling Planet, the nation's leading retail provider of renewable energy.
Sterling Planet caters to the needs of large corporations seeking to purchase RECs in large volume with economical multi-year pricing, while also serving residential customers nationwide. "We commend National Envelope, a visionary company with steadfast support of environmental causes, as shown through this major commitment to renewable energy," says Mel Jones, Sterling Planet's President and Chief Executive Officer. "We encourage other corporate citizens to follow National Envelope's example of stewardship."
About National Envelope Corporation
National Envelope is the largest envelope company in the world. Servicing the country with 21 manufacturing facilities coast-to-coast which operate utilizing the most technologically advanced folding, printing, and prepress equipment, National offers its customers unparalleled product selection and service. The company is the official converter for every major North American paper company as well as some of Europe's most prestigious mills. In addition to a full selection of envelopes, the company also offers a full range of announcement and greeting products. With over 3 billion envelopes in stock and a base of over 600 folding machines, National Envelope sets the standard for the envelope manufacturing industry.
About Sterling Planet, Inc.
Sterling Planet is the nation's leading retail provider of solar, wind and other clean, renewable energy through direct sales and electric utility partnerships. Sales to date have created environmental benefits comparable taking 613,500 cars off U.S. roads for a year. Founded in 2000, Sterling Planet was the first company to offer RECs (Renewable Energy Credits) to every U.S. home and business as a way to support sustainable energy production that benefits the environment, the economy and society in general. Today, Sterling Planet has 304 large commercial and industrial clients nationwide, including 31 utility partners in Connecticut, Florida, Massachusetts, New Jersey, New York and elsewhere. The company is also exploring emerging clean energy markets, maintaining a focus on businesses, universities, government clients and other companies seeking LEED credits for green building certification.
Sterling Planet is a division of GS Energy Corporation (OTC Bulletin Board: GSEG - News), an integrated clean energy company that was founded to facilitate the more efficient use of traditional sources of energy and the increased production and use of renewable sources of energy.
Safe Harbor Statement
This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of GS Energy Corporation, and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact:
Sterling Planet, Inc.
Phone: 877-457-2306
info@sterlingplanet.com
or
National Envelope Corporation
Rick Huntoon, 972-731-1100
rhuntoon@natenv.com
or
GS Energy Corporation
Investor Relations:
CEOcast, Inc.
Andrew Hellman, 212-732-4300
or
Public Relations:
Walek & Associates
Deborah McCandless, 212-590-0523
Fax: 212-889-7174
dmccandless@walek.com
www.walek.com
--------------------------------------------------------------------------------
Source: GS Energy Corporation
GKIS - Gold Kist Responds to Unsolicited Proposal from Pilgrim's Pride
Monday August 21, 7:58 am ET
ATLANTA--(BUSINESS WIRE)--Aug. 21, 2006--Gold Kist Inc. (NASDAQ:GKIS - News) today issued the following statement in response to Pilgrim's Pride Corporation's proposal to acquire all outstanding common shares of Gold Kist for $20 a share:
The Gold Kist Board strongly believes in the Company's ability to successfully execute our long-term strategic plan to provide significant value to our stockholders. With our strong financial position and efficient operations, we believe that we performed competitively with our peers in the recent downturn. We are confident in our previously-stated strategy to expand our private label and value-added businesses, to improve our operating efficiencies and to be an industry consolidator. This strategy, along with our experienced management, our strong customer and supplier relationships and our dedicated employees position us very well to capitalize on rapidly improving market conditions.
Since February 2006, while the poultry markets and our stock price have been depressed, Pilgrim's has made two opportunistic proposals to acquire the Company. After careful consideration by our Board of Directors and with the advice of our outside legal counsel and our financial advisor, these proposals were rejected. In June, Pilgrim's made an additional proposal to the Board of Directors. Although this proposal was unacceptable as presented to the Board and we have great confidence in our strategy as an independent company, our Board always considers opportunities to maximize stockholder value. To this end, in July we met with Pilgrim's to explore their unsolicited proposal and have expressed our willingness to consider limited reciprocal due diligence subject to an appropriate confidentiality agreement. We were therefore surprised and disappointed that Pilgrim's chose to make public its unsolicited proposal at this time.
The Board plans to carefully examine this proposal and has designated a committee to consider our strategic plans and potential alternatives to maximize stockholder value. Our Board and management will continue to faithfully discharge our duties to our stockholders and other stakeholders.
Merrill Lynch & Co. is the Company's financial advisor, and Alston & Bird LLP and Richards, Layton & Finger are outside legal counsel to Gold Kist.
We will file a proxy statement in connection with our 2007 annual meeting of stockholders. Our stockholders are strongly advised to read the proxy statement when it becomes available, as it will contain important information. Stockholders will be able to obtain the proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the Securities and Exchange Commission for free at the Internet website maintained by the Securities and Exchange Commission at www.sec.gov. Copies of the proxy statement and any amendments and supplements to the proxy statement will also be available for free at the Company's Internet website at www.goldkist.com or by writing to Gold Kist Inc., Attn: Investor Relations, 244 Perimeter Center Parkway, N.E., Atlanta, Georgia 30346. In addition, copies of the proxy materials may be requested by contacting our proxy solicitor, MacKenzie Partners, Inc. at (800) 322 2885 toll-free or by email at proxy@mackenziepartners.com. Detailed information regarding the names, affiliations and interests of individuals who may be deemed participants in the solicitation of proxies of Gold Kist Inc. stockholders is available on Schedule 14A filed with the Securities and Exchange Commission on August 21, 2006.
About Gold Kist
Gold Kist is the third largest chicken company in the United States, accounting for more than nine percent of chicken produced in the United States in 2005. Gold Kist operates a fully-integrated chicken production business that includes live production, processing, marketing and distribution. Gold Kist's operations include nine divisions located in Alabama, Florida, Georgia, North Carolina and South Carolina. For more information, visit the company's Web site at http://www.goldkist.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as defined in the federal securities laws regarding Gold Kist's beliefs, anticipations, expectations or predictions of the future, including statements relating to the Company's strategies of expanding its private label and value-added businesses, improving operating efficiencies, and becoming an industry consolidator, positioning to capitalize on improving market conditions, improvements in market conditions, and the Company's ability to successfully execute on its long-term strategic plan. These forward-looking statements involve a number of risks and uncertainties. Among the important factors that could cause actual results to differ materially from those indicated in such forward-looking statements include market conditions for finished and value-added products including competitive factors and the supply and pricing of alternative meat proteins; effectiveness of our sales and marketing programs; disease outbreaks affecting broiler production, demand and/or marketability of our products; uncertainties relating to fluctuations in the cost and availability of raw materials, such as feed ingredients; risks associated with effectively executing risk management activities; changes in the availability and relative costs of labor and contract growers; effectiveness of our capital expenditures and other cost-savings measures; contamination of products, which can lead to product liability and product recalls; access to foreign markets together with foreign economic conditions; acquisition activities and the effect of completed acquisitions; pending or future litigation; the ability to obtain additional financing or make payments on our debt; regulatory developments, industry conditions and market conditions; and general economic conditions; as well as other risks described under "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended October 1, 2005, and subsequently filed Quarterly Reports on Form 10-Q. Gold Kist undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
For Gold Kist Inc.
Media:
Brunswick Group
Steven Lipin or Erin Becker, 212-333-3810
or
Investors:
MacKenzie Partners
Larry Dennedy, 212-929-5500
--------------------------------------------------------------------------------
Source: Gold Kist Inc.
Stock futures fall on oil, Lowe's
Monday August 21, 8:10 am ET
By Caroline Valetkevitch
NEW YORK (Reuters) - U.S. stock index futures declined on Monday, pressured by a rise in oil prices before a deadline for Iran's nuclear program and a disappointing sales forecast and profit from home improvement chain Lowe's Cos. Inc. (NYSE:LOW - News)
Shares of Lowe's, the No. 2 U.S. home improvement chain behind Home Depot Inc. (NYSE:HD - News), fell 3.5 percent to $28.50 before the opening bell after the company cut its forecast for same-store sales growth and reported earnings just shy of Wall Street estimates. For details, see (ID:nN21456812).
Crude rose to nearly $72 a barrel after Iran, the world's fourth-largest oil exporter, said it would not suspend its nuclear program as its deadline to respond formally to proposals from the West drew near. (ID:nSP290784)
Tehran said on Sunday it would not suspend uranium enrichment, ruling out the main demand in a package backed by six world powers. Iran plans to reply in full by Tuesday. U.S. crude oil (CLc1) was up 83 cents at $71.97 a barrel.
S&P 500 futures (SPc1) were down 4.80 points, slightly below fair value, a mathematical formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract.
Dow Jones industrial average futures (DJc1) were down 36 points, and Nasdaq 100 (NDc1) futures were down 11.75 points.
"After a solid week of gains, it would be normal for a pullback," said Peter Cardillo, chief market analyst and chief strategist at SW Bach and Co. "We have geopolitical concerns heating up in the market place, and we have a back-up in oil prices."
On Friday, U.S. stocks closed higher for the fifth day in a row as news of the progress in Microsoft Corp.'s (NASDAQ:MSFT - News) stock-buyback program pushed the software maker's shares higher, while a federal judge's favorable ruling lifted Altria Group Inc. (NYSE:MO - News)
No major economic reports were scheduled for release on Monday, but investors will be looking ahead to U.S. home sales and durable goods figures later in the week.
Brokerage Credit Suisse lowered its rating on Ford Motor Co. (NYSE:F - News) to "underperform" from "neutral," according to a theflyonthewall.com report.
Shares of health insurer Aetna Inc. (NYSE:AET - News) could get a boost after a report in Barron's said the stock is ready to make a robust recovery. (ID:nN2067630)
SSTI - SST and TSMC Collaborate on Development and Licensing of Next-Generation 90nm SuperFlash Technology
Monday August 21, 3:05 am ET
Technology Addresses Growing Demand for Embedded Memory; Companies Commemorate 10 years of Strategic Licensing Partnership
SUNNYVALE, Calif. and HSINCHU, Taiwan, Aug. 21 /PRNewswire-FirstCall/ -- SST (Silicon Storage Technology, Inc.) (Nasdaq: SSTI - News), a leader in flash memory technology, and TSMC (Taiwan Semiconductor Manufacturing Company) today announced the two companies have signed a new technology development and licensing agreement that will offer the first licensable 90nm embedded flash technology. Under terms of the agreement, TSMC will license SST's next-generation 90nm SuperFlash technology as part of TSMC's embedded flash memory portfolio.
The embedded flash market is experiencing tremendous growth. According to the market research firm WebFeet Research, the value of the embedded flash market is expected to reach $6.7 billion by 2011. This represents a 14.4 percent compounded annual growth rate.
"The popularity of today's consumer and mobile electronics devices has created strong demand for many types of embedded memories," said Alan Niebel, CEO, WebFeet Research. "As these applications continue to increase functionality, the demand for more advanced embedded flash technologies, like SST's 90nm SuperFlash technology, will be at a premium."
SST's advanced 90nm SuperFlash technology addresses the needs of applications, such as 64-bit MCU cores, high-speed ASICs, and multimedia ICs. This high-performance, high reliability technology utilizes a split gate, source-side injection, poly-erase memory cell that is capable of true logic VDD read operation to address the demand for lower power and higher density applications. Samples will be available in 2007. The agreement is the latest between SST and TSMC and marks 10 years of collaboration.
"Our 90nm SuperFlash technology represents a significant extension to our reach in the embedded flash market," said Bing Yeh, president and CEO of SST. "The development of this next-generation memory cell is consistent with our roadmap of scaling the SuperFlash technology to finer process geometries. TSMC has been an invaluable and strategic partner for SST."
"TSMC is committed to provide the foundry industry's most advanced technologies offers to our customers," said Jason Chen, vice president of corporate development at TSMC. "Over the years, TSMC & SST's cooperation in the embedded flash technology area has been well accepted. We believe the advancements to 90nm embedded flash technology will meet the growing requirements for embedded memory business."
About TSMC
TSMC is the world's largest dedicated semiconductor foundry, providing the industry's leading process technology and the foundry industry's largest portfolio of process-proven library, IP, design tools and reference flows. The company operates two advanced 300mm wafer fabs, five eight-inch fabs and one six-inch wafer fab. TSMC also has substantial capacity commitments at its wholly-owned subsidiary, WaferTech and TSMC (Shanghai), and its joint venture fab, SSMC. In early 2001, TSMC became the first IC manufacturer to announce a 90-nm technology alignment program with its customers. TSMC's corporate headquarters are in Hsinchu, Taiwan. For more information about TSMC please see http://www.tsmc.com .
About Silicon Storage Technology, Inc.
Headquartered in Sunnyvale, California, SST designs, manufactures and markets a diversified range of memory and non-memory products for high volume applications in the digital consumer, networking, wireless communications and Internet computing markets. Leveraging its proprietary, patented SuperFlash technology, SST is a leading provider of nonvolatile memory solutions with product families that include various densities of high functionality flash memory components and flash mass storage products. The Company also offers its SuperFlash technology for embedded applications through its broad network of world-class manufacturing partners and technology licensees, including TSMC, which offers it under its trademark Emb-FLASH. SST's non-memory products include NAND controller-based products, smart card ICs, flash microcontroller and radio frequency ICs and modules. Further information on SST can be found on the company's Web site at http://www.sst.com .
Forward-Looking Statements
Except for the historical information contained herein, this news release contains forward-looking statements regarding flash memory and non-memory market conditions, SST's future financial performance, the performance of new products and SST's ability to bring new products to market that involve risks and uncertainties. These risks may include timely development, acceptance and pricing of new products, the terms and conditions associated with licensees' royalty payments, the impact of competitive products and pricing, and general economic conditions as they affect SST's customers, as well as other risks detailed from time to time in the SST's SEC reports, including the Annual Report on Form 10-K for the year ended December 31, 2005 and on Form 10-Q for the quarters ended March 31 and June 30, 2006.
For more information about SST and the company's comprehensive list of product offerings, please call 1-888/SST-CHIP. Information can also be requested via email to literature@sst.com or through SST's Web site at http://www.sst.com. SST's head office is located at 1171 Sonora Court, Sunnyvale, Calif.; telephone: 408/735-9110; fax: 408/735-9036.
The SST logo and SuperFlash are registered trademarks of Silicon Storage Technology, Inc. Emb-FLASH is a trademark of TSMC. All other trademarks or registered trademarks are the property of their respective holders.
For More Information Contact:
Sam Sambasivam
Business Development Director
Silicon Storage Technology, Inc.
408/735-9110
licensing@sst.com
Steve Gabriel
Porter Novelli
408/369-4627
steve.gabriel@porternovelli.com
Laurie Brunner
TSMC
408/382-8089
lbrunner@tsmc.com
--------------------------------------------------------------------------------
Source: Silicon Storage Technology, Inc.
EZM - EuroZinc and Lundin Mining to merge in stock deal
Monday August 21, 3:26 am ET
NEW YORK (Reuters) - EuroZinc Mining Corp. (TSX:EZM.TO - News) and Lundin Mining Corp. (TSX:LUN.TO - News) on Monday agreed to merge in a stock deal that will create a copper and zinc producer with a market capitalization of about $3 billion (C$3.3 billion).
Under terms of the deal, which will be executed through a plan of arrangement, all EuroZinc common shares will be automatically exchanged at a ratio of 0.0952 Lundin Mining common shares for each EuroZinc common share.
Lundin shareholders will continue to hold their existing common shares, the companies said.
Existing EuroZinc shareholders will own about 56.9 percent and Lundin holders will own about 43.1 percent of the combined company, which will be called Lundin Mining Corp.
The deal is conditional upon EuroZinc and Lundin shareholders approving the deal by 66.7 percent and 50.1 percent respectively, as well as other approvals.
Both sides agreed to pay a break fee to the other party of $40 million under certain circumstances and each company has granted the other a right to match a competing offer.
Lundin family interests, who hold about 19.9 percent of Lundin Mining, and Resource Capital Funds, which owns about 9.9 percent of EuroZinc, support of the deal, the companies said.
Colin Benner, who is chief executive officer of EuroZinc, will become vice chairman and CEO of the combined company and remain based in Vancouver. Karl-Axel Waplan, CEO of Lundin, will become president and chief operating officer of the combined company and remain based in Stockholm.
Both EuroZinc and Lundin Mining will be equally represented on the board, the companies said.
MITI - MedImmune Files Investigational New Drug Application for MT103
Monday August 21, 3:28 am ET
Molecule Designed to Treat Certain Lymphomas
GAITHERSBURG, Md. and CARLSBAD, Calif., Aug. 21, 2006 (PRIMEZONE) -- MedImmune, Inc. (NASDAQ:MEDI - News) and Micromet, Inc. (NASDAQ:MITI - News) today announced that MedImmune has filed an investigational new drug application (IND) with the U.S. Food & Drug Administration (FDA) for MT103 (also known as MEDI-538) for the treatment of patients with B-cell-derived non-Hodgkins lymphoma (NHL) not eligible for curative therapy. MT103 is a recombinant single-chain bispecific T-cell engager, or BiTE(R), molecule. It targets the CD19 antigen, which is uniquely expressed on B cells.
``The specific targeting of T-cells against tumor cells by MT103 represents a new approach to cancer therapy with potential benefits for patients suffering from certain lymphomas and leukemias, particularly those who have not responded to previous therapies,'' commented Dirk Reitsma, M.D., vice president, clinical development, oncology, MedImmune, Inc. ``Pending FDA review, we plan to begin dosing patients soon in a Phase 1 study designed to extend the clinical progress made to date in European studies by our partner, Micromet.''
MedImmune and Micromet AG, a wholly owned subsidiary of Micromet, Inc., entered an agreement in 2003 to jointly develop MT103. Under the terms of the companies' collaboration agreement, Micromet will receive a milestone payment from MedImmune triggered by the IND filing.
In MedImmune's planned Phase 1 open-label, single-arm, dose escalation trial in the U.S., investigators will assess the safety, tolerability and antitumor activity of continuous intravenous (IV) infusion of MT103 in patients with B-cell-derived NHL who have not responded to or have become refractory to previous therapies. Other endpoints include MT103's pharmacokinetics, pharmacodynamics, and immunogenicity as well as exploration of the molecule's mechanism of action. Doses will be given for a four-week period, with an option for an additional four weeks of therapy if disease improvement or stabilization is observed.
``We look forward to extending the clinical trial program for MT103 into the United States,'' said Carsten Reinhardt, senior vice president, clinical development, Micromet, Inc. ``Given the encouraging interim results of the ongoing European Phase 1 trial with responses seen in an extensively pretreated patient population, we hope to substantiate the therapeutic potential of this molecule.''
The ongoing Phase 1 trial being conducted by Micromet in Germany is investigating the safety and tolerability of a continuous infusion of MT103 over a four- to eight-week period at escalating dose levels in patients with relapsed, indolent B-cell NHL. In this study, approximately 20 patients have been treated to date over longer dosing periods than in previous studies. In the first three cohorts of patients in this trial (who received doses of 0.5 up to 5 micrograms per meter squared over 24 hours for four to eight weeks), no dose limiting toxicities have been observed. Evaluation of a fourth dose level, which is 15 micrograms per meter squared over 24 hours, is currently ongoing. Pharmacodynamic effects have been observed at 5 and 15 micrograms per meter squared over 24 hours with complete depletion of malignant B cells as well as significant T cell expansion in the majority of patients. Three out of five patients receiving 15 micrograms per meter squared over 24 hours of MT103 for at least two weeks showed clinical responses assessed by central radiology. One patient had a complete tumor response and two patients showed partial tumor responses according to standardized Cheson criteria. These preliminary data from the ongoing European Phase 1 trial of MT103 were presented at the 11th Congress of the European Hematology Association in June 2006 (1).
About MT103 (MEDI-538)
MT103 is a BiTE(R) molecule being developed as a potential treatment for certain types of B-cell lymphomas. BiTE(R) molecules are part of a novel class of antibody derivatives that may have the potential to selectively direct and activate the human immune system to act against cancer cells. This action is believed to occur as a result of the molecule's stimulation of T cells to target and destroy cancer cells that express a specific antigen. MT103 specifically targets the CD19 antigen, which is present on B cells, but not on other types of blood cells or healthy tissues.
In February 2006, the FDA approved an orphan drug designation for MT103 for the treatment of indolent B-cell lymphoma, excluding chronic lymphocytic leukemia and NHL with central nervous system involvement. MT103 also received orphan drug designation from the European Agency for the Evaluation of Medicinal Products (EMEA) for the treatment of mantle cell lymphoma and chronic lymphocytic leukemia.
References
(1) Bargou et al., MT103 (anti-CD19 x anti-CD3-BiTE) induces B cell depletion, clearance of bone marrow infiltration and clinical responses in heavily pre-treated NHL patients: first data from dose-escalation study MT103-104, 11th Congress of the European Hematology Association held on June 15 - 18, 2006 in Amsterdam
About MedImmune, Inc.
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 2,300 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com.
This announcement contains, in addition to historical information, certain forward-looking statements that involve risks and uncertainties, in particular, related to the research and development of a BiTE molecule targeting CD19 for the potential treatment of certain lymphomas. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors, including risks and uncertainties discussed in MedImmune's filings with the U.S. Securities and Exchange Commission. There can be no assurance that such development efforts will succeed, that such products will receive required regulatory clearance or that, even if such regulatory clearance is received, such products will ultimately achieve commercial success.
About Micromet, Inc. (http://www.micromet-inc.com)
Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. Adecatumumab (MT201), a recombinant human monoclonal antibody, is being evaluated in Phase 2 clinical trials for the treatment of patients with breast cancer and prostate cancer. MT103 is being studied in a Phase 1 clinical trial for the treatment of patients with NHL. Micromet has established a drug development platform based on its BiTE(R) technology, a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Micromet has established collaborations with MedImmune, Inc. and Serono.
This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding the efficacy, safety, and intended utilization of Micromet's product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research, discovery of new product candidates, and clinical trials, and plans regarding partnering activities. Factors that may cause actual results to differ materially include difficulties encountered in integrating merged businesses, the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risk that we will not obtain approval to market our products, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for future revenues under the terms of our existing collaboration agreements, further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words ``may,'' ``will,'' ``would,'' ``could,'' ``should,'' ``believes,'' ``estimates,'' ``projects,'' ``potential,'' ``expects,'' ``plans,'' ``anticipates,'' ``intends,'' ``continues,'' ``forecast,'' ``designed,'' ``goal,'' or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed in our periodic reports and other filings with the SEC, including the ``Risk Factors'' sections of such reports.
Contact:
MedImmune
Investors:
Peter Vozzo
301-398-4358
Media:
Jamie Lacey
301-398-4035
http://www.medimmune.com
Micromet
Investors:
Ines-Regina Buth
760-494-4235 (US)
+49 (0)89 895277 221 (Europe)
ines.buth@micromet-inc.com
Media:
Evelyn Wolf
760-494-4234 (US)
+49 (0)89 895277 220 (Europe)
evelyn.wolf@micromet-inc.com
--------------------------------------------------------------------------------
Source: Hugin Online; Micromet Inc.